all-trans-retinoic acid - Ontology Report

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	all-trans-retinoic acid	go back to main search page
Accession:	CHEBI:15367	browse the term
Definition:	A retinoic acid in which all four exocyclic double bonds have E- (trans-) geometry.
Synonyms:	exact_synonym:	(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
	related_synonym:	(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL); AGN 100335; Acide retinoique (French) (DSL); C20H28O2; CC(\\C=C\\C1=C(C)CCCC1(C)C)=C/C=C/C(C)=C/C(O)=O; InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+; InChIKey=SHGAZHPCJJPHSC-YCNIQYBTSA-N; RETINOIC ACID; Renova; Retin-A; Retisol-A; Ro 1-5488; Stieva-A; Tretin M; Tretinoine (French) (EINECS); Vesanoid; Vitamin A acid; all-(E)-Retinoic acid; all-trans-Tretinoin; all-trans-Vitamin A acid; all-trans-Vitamin A1 acid; all-trans-beta-Retinoic acid; beta-Retinoic acid; trans-Retinoic acid; tretinoin
	alt_id:	CHEBI:45376; CHEBI:8815
	xref_casrn:	302-79-4
	xref:	Beilstein:2057223 "Beilstein Registry Number"; ChEMBL:102208 "ChEMBL COMPOUND"; ChemIDplus:302-79-4 "CAS Registry Number"; CiteXplore:11073974 "PubMed citation"; CiteXplore:11214352 "PubMed citation"; CiteXplore:11332619 "PubMed citation"; CiteXplore:11343416 "PubMed citation"; CiteXplore:11437362 "PubMed citation"; CiteXplore:11556813 "PubMed citation"; CiteXplore:11722649 "PubMed citation"; CiteXplore:11896294 "PubMed citation"; CiteXplore:11904404 "PubMed citation"; CiteXplore:14581379 "PubMed citation"; CiteXplore:14605492 "PubMed citation"; CiteXplore:14627725 "PubMed citation"; CiteXplore:14704332 "PubMed citation"; CiteXplore:14705145 "PubMed citation"; CiteXplore:14978018 "PubMed citation"; CiteXplore:15194426 "PubMed citation"; CiteXplore:15318809 "PubMed citation"; CiteXplore:15327395 "PubMed citation"; CiteXplore:15359008 "PubMed citation"; CiteXplore:15376324 "PubMed citation"; CiteXplore:15476854 "PubMed citation"; CiteXplore:15537748 "PubMed citation"; CiteXplore:15539337 "PubMed citation"; CiteXplore:15675886 "PubMed citation"; CiteXplore:15839997 "PubMed citation"; CiteXplore:16569247 "PubMed citation"; CiteXplore:16685080 "PubMed citation"; CiteXplore:16688769 "PubMed citation"; CiteXplore:16720557 "PubMed citation"; CiteXplore:16819260 "PubMed citation"; CiteXplore:16847436 "PubMed citation"; CiteXplore:16920920 "PubMed citation"; CiteXplore:17073551 "PubMed citation"; CiteXplore:17166212 "PubMed citation"; CiteXplore:17204142 "PubMed citation"; CiteXplore:18052213 "PubMed citation"; CiteXplore:18085670 "PubMed citation"; CiteXplore:18162363 "PubMed citation"; CiteXplore:18183617 "PubMed citation"; CiteXplore:18318655 "PubMed citation"; CiteXplore:18322276 "PubMed citation"; CiteXplore:18400206 "PubMed citation"; CiteXplore:18404486 "PubMed citation"; CiteXplore:18440196 "PubMed citation"; CiteXplore:18678272 "PubMed citation"; CiteXplore:18819820 "PubMed citation"; CiteXplore:18977311 "PubMed citation"; CiteXplore:19112091 "PubMed citation"; CiteXplore:19144697 "PubMed citation"; CiteXplore:19427305 "PubMed citation"; CiteXplore:19587328 "PubMed citation"; CiteXplore:19597529 "PubMed citation"; CiteXplore:19814868 "PubMed citation"; CiteXplore:19841174 "PubMed citation"; CiteXplore:21898109 "PubMed citation"; CiteXplore:21924320 "PubMed citation"; CiteXplore:21993673 "PubMed citation"; CiteXplore:22134377 "PubMed citation"; CiteXplore:22177959 "PubMed citation"; CiteXplore:22180426 "PubMed citation"; CiteXplore:22244299 "PubMed citation"; CiteXplore:22261335 "PubMed citation"; CiteXplore:22428994 "PubMed citation"; CiteXplore:22514600 "PubMed citation"; CiteXplore:22532966 "PubMed citation"; CiteXplore:22534100 "PubMed citation"; CiteXplore:22538278 "PubMed citation"; CiteXplore:22741806 "PubMed citation"; DrugBank:DB00755 "DrugBank"; HMDB:HMDB01852 "HMDB"; KEGG COMPOUND:302-79-4 "CAS Registry Number"; KEGG COMPOUND:C00777 "KEGG COMPOUND"; KEGG DRUG:D00094 "KEGG DRUG"; LIPID MAPS:LMPR01090019 "LIPID MAPS instance"
	xref_mesh:	MESH:D014212
	xref:	PDBeChem:REA "PDBeChem"; Reaxys:2057223 "Reaxys Registry Number"; Wikipedia:Tretinoin "Wikipedia"
	cyclic_relationship:	is_conjugate_acid_of CHEBI:35291

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

all-trans-retinoic acid
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	AARD	alanine and arginine rich domain containing protein		increases expression	ISO	8	117,950,464	117,956,239	RGD:6480464	CTD
G	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1		multiple interactions	ISO	9	107,543,283	107,690,527	RGD:6480464	CTD
G	ABCA1	ATP-binding cassette, sub-family A (ABC1), member 1		increases expression	ISO	9	107,543,283	107,690,527	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		multiple interactions	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases acetylation	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1		increases expression	EXP	7	87,133,179	87,342,639	RGD:6480464	CTD
G	ABCB10	ATP-binding cassette, sub-family B (MDR/TAP), member 10		decreases expression	EXP	1	229,652,329	229,694,442	RGD:6480464	CTD
G	ADIRF	adipogenesis regulatory factor		increases expression	EXP	10	88,728,188	88,730,666	RGD:6480464	CTD
G	AGO1	argonaute RISC catalytic component 1		increases expression	EXP	1	36,348,810	36,389,899	RGD:6480464	CTD
G	AHCYL2	adenosylhomocysteinase-like 2		increases expression	ISO	7	128,864,855	129,070,052	RGD:6480464	CTD
G	AHR	aryl hydrocarbon receptor		increases expression	EXP	7	17,338,276	17,385,775	RGD:6480464	CTD
G	AHR	aryl hydrocarbon receptor		multiple interactions	ISO	7	17,338,276	17,385,775	RGD:6480464	CTD
G	AHR	aryl hydrocarbon receptor		multiple interactions	ISO	7	17,338,276	17,385,775	RGD:6480464	CTD
G	AICDA	activation-induced cytidine deaminase		increases expression	ISO	12	8,754,762	8,765,442	RGD:6480464	CTD
G	AIMP1	aminoacyl tRNA synthetase complex-interacting multifunctional protein 1		increases expression	EXP	4	107,236,767	107,270,382	RGD:6480464	CTD
G	AIP	aryl hydrocarbon receptor interacting protein		decreases expression	EXP	11	67,250,505	67,258,579	RGD:6480464	CTD
G	AIP	aryl hydrocarbon receptor interacting protein		increases expression	EXP	11	67,250,505	67,258,579	RGD:6480464	CTD
G	AKAP12	A kinase (PRKA) anchor protein 12		increases expression	EXP	6	151,561,134	151,679,694	RGD:6480464	CTD
G	AKAP2	A kinase (PRKA) anchor protein 2		decreases expression	ISO	9	112,810,878	112,934,792	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases response to substance	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases activity	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases phosphorylation	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		increases phosphorylation	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		increases phosphorylation	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases phosphorylation	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	ALAS1	aminolevulinate, delta-, synthase 1		increases expression	EXP	3	52,232,099	52,248,343	RGD:6480464	CTD
G	ALB	albumin		affects binding	EXP	4	74,269,972	74,287,129	RGD:6480464	CTD
G	ALB	albumin		decreases expression	EXP	4	74,269,972	74,287,129	RGD:6480464	CTD
G	ALB	albumin		multiple interactions	EXP	4	74,269,972	74,287,129	RGD:6480464	CTD
G	ALB	albumin		decreases secretion	EXP	4	74,269,972	74,287,129	RGD:6480464	CTD
G	ALB	albumin		decreases expression	ISO	4	74,269,972	74,287,129	RGD:6480464	CTD
G	ALDH1A1	aldehyde dehydrogenase 1 family, member A1		decreases expression	EXP	9	75,515,578	75,568,233	RGD:6480464	CTD
G	ALDH1A1	aldehyde dehydrogenase 1 family, member A1		decreases activity	EXP	9	75,515,578	75,568,233	RGD:6480464	CTD
G	ALDH1A1	aldehyde dehydrogenase 1 family, member A1		increases chemical synthesis	ISO	9	75,515,578	75,568,233	RGD:6480464	CTD
G	ALDH1A1	aldehyde dehydrogenase 1 family, member A1		multiple interactions	EXP	9	75,515,578	75,568,233	RGD:6480464	CTD
G	ALDH1A1	aldehyde dehydrogenase 1 family, member A1		increases expression	ISO	9	75,515,578	75,568,233	RGD:6480464	CTD
G	ALDH1A1	aldehyde dehydrogenase 1 family, member A1		increases chemical synthesis	ISO	9	75,515,578	75,568,233	RGD:6480464	CTD
G	ALDH1A2	aldehyde dehydrogenase 1 family, member A2		increases chemical synthesis	EXP	15	58,245,622	58,358,121	RGD:6480464	CTD
G	ALDH1A2	aldehyde dehydrogenase 1 family, member A2		multiple interactions	EXP	15	58,245,622	58,358,121	RGD:6480464	CTD
G	ALDH1A2	aldehyde dehydrogenase 1 family, member A2		affects chemical synthesis	ISO	15	58,245,622	58,358,121	RGD:6480464	CTD
G	ALDH1A2	aldehyde dehydrogenase 1 family, member A2		affects chemical synthesis	ISO	15	58,245,622	58,358,121	RGD:6480464	CTD
G	ALDH1A2	aldehyde dehydrogenase 1 family, member A2		increases chemical synthesis	ISO	15	58,245,622	58,358,121	RGD:6480464	CTD
G	ALDH1A3	aldehyde dehydrogenase 1 family, member A3		increases chemical synthesis	EXP	15	101,420,009	101,456,831	RGD:6480464	CTD
G	ALDH1A3	aldehyde dehydrogenase 1 family, member A3		affects chemical synthesis	ISO	15	101,420,009	101,456,831	RGD:6480464	CTD
G	ALDH1A3	aldehyde dehydrogenase 1 family, member A3		multiple interactions	ISO	15	101,420,009	101,456,831	RGD:6480464	CTD
G	ALDH1A3	aldehyde dehydrogenase 1 family, member A3		increases chemical synthesis	ISO	15	101,420,009	101,456,831	RGD:6480464	CTD
G	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)		increases expression	EXP	12	112,204,691	112,247,789	RGD:6480464	CTD
G	ALDH3A1	aldehyde dehydrogenase 3 family, member A1		decreases expression	EXP	17	19,641,297	19,651,746	RGD:6480464	CTD
G	ALDH3A1	aldehyde dehydrogenase 3 family, member A1		decreases activity	EXP	17	19,641,297	19,651,746	RGD:6480464	CTD
G	ALDH3A1	aldehyde dehydrogenase 3 family, member A1		multiple interactions	EXP	17	19,641,297	19,651,746	RGD:6480464	CTD
G	ALDH3A2	aldehyde dehydrogenase 3 family, member A2		increases expression	ISO	17	19,552,064	19,580,908	RGD:6480464	CTD
G	ALK	anaplastic lymphoma receptor tyrosine kinase		multiple interactions	EXP	2	29,415,640	30,144,477	RGD:6480464	CTD
G	ALK	anaplastic lymphoma receptor tyrosine kinase		decreases expression	EXP	2	29,415,640	30,144,477	RGD:6480464	CTD
G	ALOX15	arachidonate 15-lipoxygenase		affects expression	EXP	17	4,534,214	4,544,960	RGD:6480464	CTD
G	ALOX15	arachidonate 15-lipoxygenase		multiple interactions	EXP	17	4,534,214	4,544,960	RGD:6480464	CTD
G	ALOX5	arachidonate 5-lipoxygenase		increases expression	EXP	10	45,869,624	45,941,567	RGD:6480464	CTD
G	ALOX5AP	arachidonate 5-lipoxygenase-activating protein		increases expression	EXP	13	31,287,615	31,338,565	RGD:6480464	CTD
G	ALPL	alkaline phosphatase, liver/bone/kidney		multiple interactions	EXP	1	21,835,858	21,904,905	RGD:6480464	CTD
G	ALPL	alkaline phosphatase, liver/bone/kidney		increases activity	EXP	1	21,835,858	21,904,905	RGD:6480464	CTD
G	ALPL	alkaline phosphatase, liver/bone/kidney		multiple interactions	ISO	1	21,835,858	21,904,905	RGD:6480464	CTD
G	ALPL	alkaline phosphatase, liver/bone/kidney		increases activity	ISO	1	21,835,858	21,904,905	RGD:6480464	CTD
G	ALPL	alkaline phosphatase, liver/bone/kidney		increases expression	ISO	1	21,835,858	21,904,905	RGD:6480464	CTD
G	ALPL	alkaline phosphatase, liver/bone/kidney		multiple interactions	ISO	1	21,835,858	21,904,905	RGD:6480464	CTD
G	ALPL	alkaline phosphatase, liver/bone/kidney		multiple interactions	ISO	1	21,835,858	21,904,905	RGD:6480464	CTD
G	ALPL	alkaline phosphatase, liver/bone/kidney		increases expression	ISO	1	21,835,858	21,904,905	RGD:6480464	CTD
G	ALPL	alkaline phosphatase, liver/bone/kidney		increases activity	ISO	1	21,835,858	21,904,905	RGD:6480464	CTD
G	AMBP	alpha-1-microglobulin/bikunin precursor		affects binding	EXP	9	116,822,407	116,840,752	RGD:6480464	CTD
G	AMD1	adenosylmethionine decarboxylase 1		decreases expression	EXP	6	111,195,987	111,216,913	RGD:6480464	CTD
G	AMOT	angiomotin		increases expression	ISO	X	112,018,105	112,084,043	RGD:6480464	CTD
G	AMY1C	amylase, alpha 1C (salivary)		decreases expression	ISO	1	104,292,441	104,301,310	RGD:6480464	CTD
G	ANAPC5	anaphase promoting complex subunit 5		increases expression	EXP	12	121,746,048	121,792,012	RGD:6480464	CTD
G	ANGPT2	angiopoietin 2		increases expression	EXP	8	6,357,172	6,420,784	RGD:6480464	CTD
G	ARNTL	aryl hydrocarbon receptor nuclear translocator-like		multiple interactions	ISO	11	13,299,325	13,408,813	RGD:6480464	CTD
G	ARNTL	aryl hydrocarbon receptor nuclear translocator-like		increases expression	ISO	11	13,299,325	13,408,813	RGD:6480464	CTD
G	ARPC3	actin related protein 2/3 complex, subunit 3, 21kDa		increases expression	EXP	12	110,872,706	110,888,158	RGD:6480464	CTD
G	ASF1B	ASF1 anti-silencing function 1 homolog B (S. cerevisiae)		decreases expression	EXP	19	14,230,321	14,247,440	RGD:6480464	CTD
G	ASL	argininosuccinate lyase		increases expression	EXP	7	65,540,776	65,558,330	RGD:6480464	CTD
G	ASNA1	arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)		increases expression	EXP	19	12,848,306	12,859,137	RGD:6480464	CTD
G	ASS1	argininosuccinate synthase 1		decreases expression	EXP	9	133,320,094	133,376,661	RGD:6480464	CTD
G	ATAD2	ATPase family, AAA domain containing 2		decreases expression	EXP	8	124,332,090	124,408,705	RGD:6480464	CTD
G	ATF2	activating transcription factor 2		affects localization	ISO	2	175,936,978	176,032,934	RGD:6480464	CTD
G	ATF6	activating transcription factor 6		increases expression	EXP	1	161,736,034	161,933,860	RGD:6480464	CTD
G	ATOH1	atonal homolog 1 (Drosophila)		increases expression	EXP	4	94,750,078	94,751,142	RGD:6480464	CTD
G	ATP13A3	ATPase type 13A3		decreases expression	EXP	3	194,123,403	194,188,968	RGD:6480464	CTD
G	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide		increases expression	ISO	17	7,554,254	7,561,089	RGD:6480464	CTD
G	ATP2A2	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2		decreases expression	EXP	12	110,719,032	110,788,898	RGD:6480464	CTD
G	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A		increases expression	EXP	3	113,465,866	113,530,905	RGD:6480464	CTD
G	ATP7A	ATPase, Cu++ transporting, alpha polypeptide		increases expression	EXP	X	77,166,194	77,305,892	RGD:6480464	CTD
G	ATPIF1	ATPase inhibitory factor 1		multiple interactions	EXP	1	28,562,602	28,564,616	RGD:6480464	CTD
G	AURKAIP1	aurora kinase A interacting protein 1		decreases expression	EXP	1	1,309,110	1,310,818	RGD:6480464	CTD
G	AURKB	aurora kinase B		decreases expression	EXP	17	8,108,049	8,113,944	RGD:6480464	CTD
G	AURKB	aurora kinase B		increases expression	ISO	17	8,108,049	8,113,944	RGD:6480464	CTD
G	AURKC	aurora kinase C		increases expression	ISO	19	57,742,377	57,746,916	RGD:6480464	CTD
G	AVP	arginine vasopressin		increases expression	ISO	20	3,063,202	3,065,370	RGD:6480464	CTD
G	B2M	beta-2-microglobulin		increases expression	ISO	15	45,003,685	45,010,357	RGD:6480464	CTD
G	B2M	beta-2-microglobulin		increases expression	EXP	15	45,003,685	45,010,357	RGD:6480464	CTD
G	B3GNT1	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1		decreases expression	ISO	11	66,112,843	66,115,161	RGD:6480464	CTD
G	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2		decreases expression	ISO	2	62,423,262	62,451,866	RGD:6480464	CTD
G	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5		increases expression	EXP	20	48,249,482	48,330,421	RGD:6480464	CTD
G	BACE1	beta-site APP-cleaving enzyme 1		affects localization	EXP	11	117,156,402	117,186,972	RGD:6480464	CTD
G	BACE1	beta-site APP-cleaving enzyme 1		increases expression	EXP	11	117,156,402	117,186,972	RGD:6480464	CTD
G	BACE1	beta-site APP-cleaving enzyme 1		increases expression	EXP	11	117,156,402	117,186,972	RGD:6480464	CTD
G	BACE1	beta-site APP-cleaving enzyme 1		increases expression	ISO	11	117,156,402	117,186,972	RGD:6480464	CTD
G	BAD	BCL2-associated agonist of cell death		decreases phosphorylation	EXP	11	64,037,300	64,052,176	RGD:6480464	CTD
G	BAD	BCL2-associated agonist of cell death		multiple interactions	EXP	11	64,037,300	64,052,176	RGD:6480464	CTD
G	BAD	BCL2-associated agonist of cell death		increases expression	EXP	11	64,037,300	64,052,176	RGD:6480464	CTD
G	BAIAP2L1	BAI1-associated protein 2-like 1		increases expression	ISO	7	97,920,962	98,030,427	RGD:6480464	CTD
G	BAK1	BCL2-antagonist/killer 1		multiple interactions	EXP	6	33,540,323	33,548,070	RGD:6480464	CTD
G	BAK1	BCL2-antagonist/killer 1		increases expression	EXP	6	33,540,323	33,548,070	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases cleavage	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		affects localization	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BBC3	BCL2 binding component 3		multiple interactions	EXP	19	47,724,079	47,736,023	RGD:6480464	CTD
G	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1		increases expression	EXP	11	27,062,509	27,149,354	RGD:6480464	CTD
G	BCAR1	breast cancer anti-estrogen resistance 1		increases expression	ISO	16	75,262,928	75,301,951	RGD:6480464	CTD
G	BCCIP	BRCA2 and CDKN1A interacting protein		increases expression	EXP	10	127,512,104	127,542,264	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		increases phosphorylation	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		increases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2A1	BCL2-related protein A1		multiple interactions	EXP	15	80,253,232	80,263,643	RGD:6480464	CTD
G	BCL2A1	BCL2-related protein A1		increases expression	EXP	15	80,253,232	80,263,643	RGD:6480464	CTD
G	BCL2A1	BCL2-related protein A1		multiple interactions	EXP	15	80,253,232	80,263,643	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		multiple interactions	EXP	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BMP7	bone morphogenetic protein 7		increases expression	ISO	20	55,743,809	55,841,707	RGD:6480464	CTD
G	BNIP3	BCL2/adenovirus E1B 19kDa interacting protein 3		multiple interactions	ISO	10	133,781,204	133,795,435	RGD:6480464	CTD
G	BOC	BOC cell adhesion associated, oncogene regulated		increases expression	ISO	3	112,931,375	113,006,306	RGD:6480464	CTD
G	BRAF	v-raf murine sarcoma viral oncogene homolog B1		decreases expression	EXP	7	140,433,812	140,624,564	RGD:6480464	CTD
G	BRCA1	breast cancer 1, early onset		increases expression	EXP	17	41,196,312	41,277,500	RGD:6480464	CTD
G	BRCA1	breast cancer 1, early onset		increases expression	ISO	17	41,196,312	41,277,500	RGD:6480464	CTD
G	BTC	betacellulin		decreases expression	EXP	4	75,671,448	75,719,882	RGD:6480464	CTD
G	BTG1	B-cell translocation gene 1, anti-proliferative		increases expression	EXP	12	92,534,054	92,539,673	RGD:6480464	CTD
G	BTG2	BTG family, member 2		affects localization	EXP	1	203,274,664	203,278,730	RGD:6480464	CTD
G	BTG2	BTG family, member 2		affects response to substance	EXP	1	203,274,664	203,278,730	RGD:6480464	CTD
G	BTG2	BTG family, member 2		increases expression	EXP	1	203,274,664	203,278,730	RGD:6480464	CTD
G	BTG2	BTG family, member 2		multiple interactions	EXP	1	203,274,664	203,278,730	RGD:6480464	CTD
G	BTN2A2	butyrophilin, subfamily 2, member A2		increases expression	ISO	6	26,383,324	26,395,102	RGD:6480464	CTD
G	BZW1	basic leucine zipper and W2 domains 1		decreases expression	ISO	2	201,676,269	201,688,569	RGD:6480464	CTD
G	C2orf54	chromosome 2 open reading frame 54		increases expression	EXP	2	241,825,465	241,835,573	RGD:6480464	CTD
G	C9orf3	chromosome 9 open reading frame 3		increases expression	EXP	9	97,488,951	97,849,500	RGD:6480464	CTD
G	CA14	carbonic anhydrase XIV		decreases expression	ISO	1	150,230,218	150,237,478	RGD:6480464	CTD
G	CA2	carbonic anhydrase II		increases expression	EXP	8	86,376,131	86,393,721	RGD:6480464	CTD
G	CA2	carbonic anhydrase II		increases activity	EXP	8	86,376,131	86,393,721	RGD:6480464	CTD
G	CA6	carbonic anhydrase VI		increases expression	EXP	1	9,005,893	9,035,151	RGD:6480464	CTD
G	CACNA1A	calcium channel, voltage-dependent, P/Q type, alpha 1A subunit		decreases expression	ISO	19	13,317,256	13,617,274	RGD:6480464	CTD
G	CACNG5	calcium channel, voltage-dependent, gamma subunit 5		increases expression	ISO	17	64,873,391	64,881,395	RGD:6480464	CTD
G	CADM1	cell adhesion molecule 1		increases expression	EXP	11	115,044,345	115,375,241	RGD:6480464	CTD
G	CALCOCO2	calcium binding and coiled-coil domain 2		increases expression	ISO	17	46,908,350	46,942,607	RGD:6480464	CTD
G	CAMK2B	calcium/calmodulin-dependent protein kinase II beta		multiple interactions	ISO	7	44,256,749	44,365,230	RGD:6480464	CTD
G	CAMK2G	calcium/calmodulin-dependent protein kinase II gamma		multiple interactions	EXP	10	75,572,259	75,634,349	RGD:6480464	CTD
G	CAPN1	calpain 1, (mu/I) large subunit		decreases activity	ISO	11	64,948,686	64,979,477	RGD:6480464	CTD
G	CAPN1	calpain 1, (mu/I) large subunit		decreases expression	ISO	11	64,948,686	64,979,477	RGD:6480464	CTD
G	CAPN10	calpain 10		increases expression	EXP	2	241,526,133	241,538,526	RGD:6480464	CTD
G	CAPN2	calpain 2, (m/II) large subunit		multiple interactions	ISO	1	223,889,295	223,963,720	RGD:6480464	CTD
G	CAPN2	calpain 2, (m/II) large subunit		decreases activity	ISO	1	223,889,295	223,963,720	RGD:6480464	CTD
G	CAPN2	calpain 2, (m/II) large subunit		decreases expression	ISO	1	223,889,295	223,963,720	RGD:6480464	CTD
G	CAPZA1	capping protein (actin filament) muscle Z-line, alpha 1		decreases expression	EXP	1	113,162,075	113,214,241	RGD:6480464	CTD
G	CASD1	CAS1 domain containing 1		affects expression	ISO	7	94,139,170	94,186,331	RGD:6480464	CTD
G	CASP1	caspase 1, apoptosis-related cysteine peptidase		multiple interactions	EXP	11	104,896,235	104,905,884	RGD:6480464	CTD
G	CASP12	caspase 12 (gene/pseudogene)		multiple interactions	EXP	11	104,756,445	104,769,397	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases expression	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases activity	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases cleavage	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases expression	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases activity	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases expression	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		multiple interactions	EXP	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		multiple interactions	EXP	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		increases expression	EXP	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		multiple interactions	ISO	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		increases cleavage	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CCNA2	cyclin A2		increases expression	ISO	4	122,737,599	122,745,088	RGD:6480464	CTD
G	CCNA2	cyclin A2		increases expression	ISO	4	122,737,599	122,745,088	RGD:6480464	CTD
G	CCNB1	cyclin B1		decreases expression	EXP	5	68,462,837	68,474,072	RGD:6480464	CTD
G	CCNB2	cyclin B2		decreases expression	EXP	15	59,397,284	59,417,244	RGD:6480464	CTD
G	CCNB2	cyclin B2		increases expression	ISO	15	59,397,284	59,417,244	RGD:6480464	CTD
G	CCND1	cyclin D1		multiple interactions	EXP	11	69,455,873	69,469,242	RGD:6480464	CTD
G	CCND1	cyclin D1		decreases response to substance	EXP	11	69,455,873	69,469,242	RGD:6480464	CTD
G	CCND1	cyclin D1		decreases expression	EXP	11	69,455,873	69,469,242	RGD:6480464	CTD
G	CCND1	cyclin D1		multiple interactions	EXP	11	69,455,873	69,469,242	RGD:6480464	CTD
G	CCND1	cyclin D1		multiple interactions	EXP	11	69,455,873	69,469,242	RGD:6480464	CTD
G	CCND1	cyclin D1		decreases expression	EXP	11	69,455,873	69,469,242	RGD:6480464	CTD
G	CCND1	cyclin D1		increases expression	ISO	11	69,455,873	69,469,242	RGD:6480464	CTD
G	CCND1	cyclin D1		decreases expression	ISO	11	69,455,873	69,469,242	RGD:6480464	CTD
G	CCND1	cyclin D1		increases ubiquitination	EXP	11	69,455,873	69,469,242	RGD:6480464	CTD
G	CCND2	cyclin D2		increases expression	EXP	12	4,382,902	4,414,522	RGD:6480464	CTD
G	CCND2	cyclin D2		increases expression	EXP	12	4,382,902	4,414,522	RGD:6480464	CTD
G	CCND3	cyclin D3		multiple interactions	EXP	6	41,902,671	42,016,610	RGD:6480464	CTD
G	CCND3	cyclin D3		multiple interactions	EXP	6	41,902,671	42,016,610	RGD:6480464	CTD
G	CCND3	cyclin D3		multiple interactions	EXP	6	41,902,671	42,016,610	RGD:6480464	CTD
G	CCND3	cyclin D3		decreases expression	EXP	6	41,902,671	42,016,610	RGD:6480464	CTD
G	CCND3	cyclin D3		multiple interactions	EXP	6	41,902,671	42,016,610	RGD:6480464	CTD
G	CCND3	cyclin D3		increases expression	EXP	6	41,902,671	42,016,610	RGD:6480464	CTD
G	CCND3	cyclin D3		decreases expression	ISO	6	41,902,671	42,016,610	RGD:6480464	CTD
G	CCND3	cyclin D3		increases expression	EXP	6	41,902,671	42,016,610	RGD:6480464	CTD
G	CCND3	cyclin D3		multiple interactions	ISO	6	41,902,671	42,016,610	RGD:6480464	CTD
G	CCND3	cyclin D3		decreases expression	ISO	6	41,902,671	42,016,610	RGD:6480464	CTD
G	CCNE1	cyclin E1		multiple interactions	EXP	19	30,302,901	30,315,215	RGD:6480464	CTD
G	CCNE1	cyclin E1		multiple interactions	EXP	19	30,302,901	30,315,215	RGD:6480464	CTD
G	CCNE1	cyclin E1		multiple interactions	EXP	19	30,302,901	30,315,215	RGD:6480464	CTD
G	CCNE1	cyclin E1		decreases expression	EXP	19	30,302,901	30,315,215	RGD:6480464	CTD
G	CCNE1	cyclin E1		decreases expression	EXP	19	30,302,901	30,315,215	RGD:6480464	CTD
G	CCNE1	cyclin E1		multiple interactions	ISO	19	30,302,901	30,315,215	RGD:6480464	CTD
G	CCNE1	cyclin E1		increases expression	ISO	19	30,302,901	30,315,215	RGD:6480464	CTD
G	CCNE1	cyclin E1		decreases expression	ISO	19	30,302,901	30,315,215	RGD:6480464	CTD
G	CCNE2	cyclin E2		decreases expression	EXP	8	95,892,452	95,907,482	RGD:6480464	CTD
G	CCNH	cyclin H		multiple interactions	EXP	5	86,690,079	86,708,850	RGD:6480464	CTD
G	CCNH	cyclin H		decreases activity	EXP	5	86,690,079	86,708,850	RGD:6480464	CTD
G	CCNT1	cyclin T1		increases expression	EXP	12	49,082,241	49,110,781	RGD:6480464	CTD
G	CCR1	chemokine (C-C motif) receptor 1		increases expression	EXP	3	46,243,200	46,249,832	RGD:6480464	CTD
G	CCR2	chemokine (C-C motif) receptor 2		increases expression	EXP	3	46,395,235	46,402,413	RGD:6480464	CTD
G	CCR3	chemokine (C-C motif) receptor 3		increases expression	EXP	3	46,283,872	46,308,197	RGD:6480464	CTD
G	CCR6	chemokine (C-C motif) receptor 6		increases expression	EXP	6	167,525,295	167,552,629	RGD:6480464	CTD
G	CCRN4L	CCR4 carbon catabolite repression 4-like (S. cerevisiae)		decreases expression	ISO	4	139,936,943	139,967,093	RGD:6480464	CTD
G	CD14	CD14 molecule		multiple interactions	EXP	5	140,011,313	140,013,286	RGD:6480464	CTD
G	CD14	CD14 molecule		multiple interactions	EXP	5	140,011,313	140,013,286	RGD:6480464	CTD
G	CD14	CD14 molecule		multiple interactions	EXP	5	140,011,313	140,013,286	RGD:6480464	CTD
G	CD14	CD14 molecule		increases expression	EXP	5	140,011,313	140,013,286	RGD:6480464	CTD
G	CD14	CD14 molecule		increases expression	EXP	5	140,011,313	140,013,286	RGD:6480464	CTD
G	CD14	CD14 molecule		multiple interactions	ISO	5	140,011,313	140,013,286	RGD:6480464	CTD
G	CD1D	CD1d molecule		multiple interactions	EXP	1	158,149,737	158,156,217	RGD:6480464	CTD
G	CD1D	CD1d molecule		increases expression	EXP	1	158,149,737	158,156,217	RGD:6480464	CTD
G	CD1D	CD1d molecule		increases expression	ISO	1	158,149,737	158,156,217	RGD:6480464	CTD
G	CD1D	CD1d molecule		increases expression	ISO	1	158,149,737	158,156,217	RGD:6480464	CTD
G	CD2AP	CD2-associated protein		multiple interactions	ISO	6	47,445,525	47,594,999	RGD:6480464	CTD
G	CD33	CD33 molecule		multiple interactions	EXP	19	51,728,335	51,743,274	RGD:6480464	CTD
G	CD33	CD33 molecule		increases expression	EXP	19	51,728,335	51,743,274	RGD:6480464	CTD
G	CD34	CD34 molecule		multiple interactions	EXP	1	208,059,883	208,084,683	RGD:6480464	CTD
G	CD36	CD36 molecule (thrombospondin receptor)		multiple interactions	ISO	7	80,231,504	80,308,593	RGD:6480464	CTD
G	CD36	CD36 molecule (thrombospondin receptor)		increases expression	ISO	7	80,231,504	80,308,593	RGD:6480464	CTD
G	CD37	CD37 molecule		decreases expression	ISO	19	49,838,677	49,843,863	RGD:6480464	CTD
G	CD38	CD38 molecule		multiple interactions	EXP	4	15,779,931	15,850,706	RGD:6480464	CTD
G	CD38	CD38 molecule		multiple interactions	EXP	4	15,779,931	15,850,706	RGD:6480464	CTD
G	CD38	CD38 molecule		increases expression	EXP	4	15,779,931	15,850,706	RGD:6480464	CTD
G	CD38	CD38 molecule		increases expression	EXP	4	15,779,931	15,850,706	RGD:6480464	CTD
G	CD3G	CD3g molecule, gamma (CD3-TCR complex)		increases expression	EXP	11	118,215,059	118,224,497	RGD:6480464	CTD
G	CD4	CD4 molecule		increases expression	EXP	12	6,898,638	6,929,976	RGD:6480464	CTD
G	CD40	CD40 molecule, TNF receptor superfamily member 5		multiple interactions	EXP	20	44,746,906	44,758,384	RGD:6480464	CTD
G	CD40	CD40 molecule, TNF receptor superfamily member 5		increases expression	EXP	20	44,746,906	44,758,384	RGD:6480464	CTD
G	CD40LG	CD40 ligand		multiple interactions	EXP	X	135,730,336	135,742,549	RGD:6480464	CTD
G	CD44	CD44 molecule (Indian blood group)		increases expression	ISO	11	35,160,417	35,253,949	RGD:6480464	CTD
G	CD44	CD44 molecule (Indian blood group)		decreases expression	EXP	11	35,160,417	35,253,949	RGD:6480464	CTD
G	CD52	CD52 molecule		increases expression	EXP	1	26,644,411	26,647,014	RGD:6480464	CTD
G	CD53	CD53 molecule		multiple interactions	EXP	1	111,413,821	111,442,558	RGD:6480464	CTD
G	CD53	CD53 molecule		increases expression	EXP	1	111,413,821	111,442,558	RGD:6480464	CTD
G	CD55	CD55 molecule, decay accelerating factor for complement (Cromer blood group)		increases expression	EXP	1	207,494,817	207,534,311	RGD:6480464	CTD
G	CD80	CD80 molecule		increases expression	EXP	3	119,243,140	119,278,481	RGD:6480464	CTD
G	CD83	CD83 molecule		multiple interactions	EXP	6	14,117,487	14,137,149	RGD:6480464	CTD
G	CD83	CD83 molecule		increases expression	EXP	6	14,117,487	14,137,149	RGD:6480464	CTD
G	CD86	CD86 molecule		increases expression	EXP	3	121,774,209	121,839,990	RGD:6480464	CTD
G	CD9	CD9 molecule		decreases expression	EXP	12	6,309,482	6,347,437	RGD:6480464	CTD
G	CDC45	cell division cycle 45		decreases expression	EXP	22	19,467,414	19,508,135	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		multiple interactions	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		multiple interactions	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		affects localization	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		multiple interactions	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		multiple interactions	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		multiple interactions	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		increases expression	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		increases expression	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		increases expression	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		increases phosphorylation	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		multiple interactions	EXP	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		affects localization	ISO	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1B	cyclin-dependent kinase inhibitor 1B (p27, Kip1)		increases phosphorylation	ISO	12	12,870,302	12,875,305	RGD:6480464	CTD
G	CDKN1C	cyclin-dependent kinase inhibitor 1C (p57, Kip2)		decreases expression	EXP	11	2,904,448	2,906,995	RGD:6480464	CTD
G	CDKN2A	cyclin-dependent kinase inhibitor 2A		increases expression	EXP	9	21,967,751	21,994,490	RGD:6480464	CTD
G	CDKN2A	cyclin-dependent kinase inhibitor 2A		decreases expression	EXP	9	21,967,751	21,994,490	RGD:6480464	CTD
G	CDKN2B	cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)		increases expression	EXP	9	22,002,902	22,009,312	RGD:6480464	CTD
G	CDKN2C	cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)		increases expression	EXP	1	51,434,367	51,440,309	RGD:6480464	CTD
G	CDKN2D	cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)		increases expression	EXP	19	10,677,138	10,679,655	RGD:6480464	CTD
G	CDT1	chromatin licensing and DNA replication factor 1		decreases expression	EXP	16	88,870,186	88,875,666	RGD:6480464	CTD
G	CDV3	CDV3 homolog (mouse)		increases expression	ISO	3	133,292,434	133,309,118	RGD:6480464	CTD
G	CDX1	caudal type homeobox 1		increases expression	ISO	5	149,546,344	149,564,121	RGD:6480464	CTD
G	CEBPA	CCAAT/enhancer binding protein (C/EBP), alpha		multiple interactions	EXP	19	33,790,840	33,793,430	RGD:6480464	CTD
G	CEBPA	CCAAT/enhancer binding protein (C/EBP), alpha		multiple interactions	EXP	19	33,790,840	33,793,430	RGD:6480464	CTD
G	CEBPA	CCAAT/enhancer binding protein (C/EBP), alpha		multiple interactions	EXP	19	33,790,840	33,793,430	RGD:6480464	CTD
G	CEBPA	CCAAT/enhancer binding protein (C/EBP), alpha		multiple interactions	ISO	19	33,790,840	33,793,430	RGD:6480464	CTD
G	CEBPA	CCAAT/enhancer binding protein (C/EBP), alpha		increases activity	EXP	19	33,790,840	33,793,430	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		affects localization	EXP	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		multiple interactions	EXP	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		multiple interactions	EXP	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		multiple interactions	EXP	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		increases activity	EXP	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		increases expression	EXP	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		increases expression	EXP	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		increases expression	EXP	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		increases expression	ISO	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPD	CCAAT/enhancer binding protein (C/EBP), delta		decreases expression	ISO	8	48,649,476	48,650,726	RGD:6480464	CTD
G	CEBPE	CCAAT/enhancer binding protein (C/EBP), epsilon		multiple interactions	EXP	14	23,586,515	23,588,820	RGD:6480464	CTD
G	CEBPE	CCAAT/enhancer binding protein (C/EBP), epsilon		multiple interactions	EXP	14	23,586,515	23,588,820	RGD:6480464	CTD
G	CEBPE	CCAAT/enhancer binding protein (C/EBP), epsilon		multiple interactions	EXP	14	23,586,515	23,588,820	RGD:6480464	CTD
G	CEBPE	CCAAT/enhancer binding protein (C/EBP), epsilon		multiple interactions	EXP	14	23,586,515	23,588,820	RGD:6480464	CTD
G	CEBPE	CCAAT/enhancer binding protein (C/EBP), epsilon		increases expression	EXP	14	23,586,515	23,588,820	RGD:6480464	CTD
G	CEBPE	CCAAT/enhancer binding protein (C/EBP), epsilon		increases expression	EXP	14	23,586,515	23,588,820	RGD:6480464	CTD
G	CEBPE	CCAAT/enhancer binding protein (C/EBP), epsilon		multiple interactions	EXP	14	23,586,515	23,588,820	RGD:6480464	CTD
G	CEBPG	CCAAT/enhancer binding protein (C/EBP), gamma		decreases expression	EXP	19	33,864,575	33,873,592	RGD:6480464	CTD
G	CEBPZ	CCAAT/enhancer binding protein (C/EBP), zeta		decreases expression	EXP	2	37,428,772	37,458,740	RGD:6480464	CTD
G	CELF4	CUGBP, Elav-like family member 4		decreases expression	ISO	18	34,823,003	35,146,000	RGD:6480464	CTD
G	CFB	complement factor B		increases expression	EXP	6	31,913,721	31,919,861	RGD:6480464	CTD
G	CFL1	cofilin 1 (non-muscle)		affects expression	ISO	11	65,622,282	65,625,804	RGD:6480464	CTD
G	CFLAR	CASP8 and FADD-like apoptosis regulator		multiple interactions	EXP	2	201,980,877	202,037,411	RGD:6480464	CTD
G	CFLAR	CASP8 and FADD-like apoptosis regulator		multiple interactions	EXP	2	201,980,877	202,037,411	RGD:6480464	CTD
G	CFTR	cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)		decreases expression	ISO	7	117,120,017	117,308,719	RGD:6480464	CTD
G	CGB	chorionic gonadotropin, beta polypeptide		increases expression	EXP	19	49,526,126	49,527,632	RGD:6480464	CTD
G	CHAT	choline O-acetyltransferase		multiple interactions	ISO	10	50,817,141	50,873,150	RGD:6480464	CTD
G	CHAT	choline O-acetyltransferase		increases expression	ISO	10	50,817,141	50,873,150	RGD:6480464	CTD
G	CHAT	choline O-acetyltransferase		increases expression	ISO	10	50,817,141	50,873,150	RGD:6480464	CTD
G	CHI3L1	chitinase 3-like 1 (cartilage glycoprotein-39)		increases expression	EXP	1	203,148,059	203,155,922	RGD:6480464	CTD
G	CHRNA3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		increases expression	ISO	15	78,885,394	78,913,637	RGD:6480464	CTD
G	CHRNA3	cholinergic receptor, nicotinic, alpha 3 (neuronal)		multiple interactions	ISO	15	78,885,394	78,913,637	RGD:6480464	CTD
G	CHRNA4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		decreases expression	ISO	20	61,974,662	61,992,748	RGD:6480464	CTD
G	CHRNA4	cholinergic receptor, nicotinic, alpha 4 (neuronal)		multiple interactions	ISO	20	61,974,662	61,992,748	RGD:6480464	CTD
G	CHRNA7	cholinergic receptor, nicotinic, alpha 7 (neuronal)		increases expression	ISO	15	32,322,686	32,462,384	RGD:6480464	CTD
G	CHRNB2	cholinergic receptor, nicotinic, beta 2 (neuronal)		increases expression	ISO	1	154,540,257	154,552,354	RGD:6480464	CTD
G	CHRNE	cholinergic receptor, nicotinic, epsilon (muscle)		increases expression	ISO	17	4,801,064	4,806,369	RGD:6480464	CTD
G	CHST15	carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15		increases expression	EXP	10	125,767,182	125,853,123	RGD:6480464	CTD
G	CIAO1	cytosolic iron-sulfur protein assembly 1		decreases expression	EXP	2	96,931,884	96,939,917	RGD:6480464	CTD
G	CIDEA	cell death-inducing DFFA-like effector a		increases expression	ISO	18	12,254,318	12,277,594	RGD:6480464	CTD
G	CIITA	class II, major histocompatibility complex, transactivator		increases expression	EXP	16	10,971,055	11,018,840	RGD:6480464	CTD
G	CITED2	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2		increases expression	EXP	6	139,693,392	139,695,787	RGD:6480464	CTD
G	CKB	creatine kinase, brain		decreases expression	EXP	14	103,985,995	103,989,196	RGD:6480464	CTD
G	CLCN4	chloride channel, voltage-sensitive 4		increases expression	ISO	X	10,124,985	10,205,700	RGD:6480464	CTD
G	CLDN4	claudin 4		increases expression	ISO	7	73,245,193	73,247,015	RGD:6480464	CTD
G	CLDN6	claudin 6		increases expression	ISO	16	3,064,713	3,068,188	RGD:6480464	CTD
G	CLDN7	claudin 7		increases expression	ISO	17	7,163,222	7,166,512	RGD:6480464	CTD
G	COX6A2	cytochrome c oxidase subunit VIa polypeptide 2		increases expression	ISO	16	31,439,052	31,439,749	RGD:6480464	CTD
G	CPE	carboxypeptidase E		increases expression	ISO	4	166,300,097	166,419,482	RGD:6480464	CTD
G	CPT1A	carnitine palmitoyltransferase 1A (liver)		increases expression	ISO	11	68,522,088	68,609,399	RGD:6480464	CTD
G	CPT1B	carnitine palmitoyltransferase 1B (muscle)		increases expression	ISO	22	51,007,290	51,017,096	RGD:6480464	CTD
G	CR2	complement component (3d/Epstein Barr virus) receptor 2		multiple interactions	EXP	1	207,627,645	207,663,240	RGD:6480464	CTD
G	CRABP1	cellular retinoic acid binding protein 1		decreases response to substance	EXP	15	78,632,666	78,640,572	RGD:6480464	CTD
G	CRABP1	cellular retinoic acid binding protein 1		increases expression	EXP	15	78,632,666	78,640,572	RGD:6480464	CTD
G	CRABP1	cellular retinoic acid binding protein 1		increases expression	EXP	15	78,632,666	78,640,572	RGD:6480464	CTD
G	CRABP1	cellular retinoic acid binding protein 1		increases expression	ISO	15	78,632,666	78,640,572	RGD:6480464	CTD
G	CRABP1	cellular retinoic acid binding protein 1		affects binding	ISO	15	78,632,666	78,640,572	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		increases response to substance	EXP	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		multiple interactions	EXP	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		multiple interactions	EXP	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		multiple interactions	EXP	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		affects binding	EXP	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		multiple interactions	EXP	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		increases expression	EXP	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		affects expression	ISO	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		affects binding	ISO	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		increases expression	ISO	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		increases expression	ISO	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CRABP2	cellular retinoic acid binding protein 2		increases expression	ISO	1	156,669,398	156,675,608	RGD:6480464	CTD
G	CREB1	cAMP responsive element binding protein 1		multiple interactions	EXP	2	208,394,616	208,470,284	RGD:6480464	CTD
G	CREB1	cAMP responsive element binding protein 1		increases activity	EXP	2	208,394,616	208,470,284	RGD:6480464	CTD
G	CREB1	cAMP responsive element binding protein 1		increases phosphorylation	EXP	2	208,394,616	208,470,284	RGD:6480464	CTD
G	CREBBP	CREB binding protein		multiple interactions	EXP	16	3,775,055	3,930,121	RGD:6480464	CTD
G	CREBBP	CREB binding protein		multiple interactions	EXP	16	3,775,055	3,930,121	RGD:6480464	CTD
G	CREBBP	CREB binding protein		multiple interactions	EXP	16	3,775,055	3,930,121	RGD:6480464	CTD
G	CREBBP	CREB binding protein		multiple interactions	EXP	16	3,775,055	3,930,121	RGD:6480464	CTD
G	CREBBP	CREB binding protein		multiple interactions	ISO	16	3,775,055	3,930,121	RGD:6480464	CTD
G	CREG1	cellular repressor of E1A-stimulated genes 1		increases expression	EXP	1	167,510,250	167,523,056	RGD:6480464	CTD
G	CRISP1	cysteine-rich secretory protein 1		decreases expression	ISO	6	49,801,970	49,844,809	RGD:6480464	CTD
G	CRKL	v-crk sarcoma virus CT10 oncogene homolog (avian)-like		multiple interactions	ISO	22	21,271,714	21,308,037	RGD:6480464	CTD
G	CRYAB	crystallin, alpha B		increases expression	EXP	11	111,779,350	111,782,473	RGD:6480464	CTD
G	CRYGB	crystallin, gamma B		increases expression	ISO	2	209,007,297	209,010,877	RGD:6480464	CTD
G	CRYGC	crystallin, gamma C		increases expression	ISO	2	208,992,861	208,994,554	RGD:6480464	CTD
G	CSE1L	CSE1 chromosome segregation 1-like (yeast)		multiple interactions	EXP	20	47,662,783	47,713,497	RGD:6480464	CTD
G	CSE1L	CSE1 chromosome segregation 1-like (yeast)		decreases expression	EXP	20	47,662,783	47,713,497	RGD:6480464	CTD
G	CSF1R	colony stimulating factor 1 receptor		multiple interactions	EXP	5	149,432,854	149,492,935	RGD:6480464	CTD
G	CSF1R	colony stimulating factor 1 receptor		multiple interactions	EXP	5	149,432,854	149,492,935	RGD:6480464	CTD
G	CSF1R	colony stimulating factor 1 receptor		increases response to substance	EXP	5	149,432,854	149,492,935	RGD:6480464	CTD
G	CSF1R	colony stimulating factor 1 receptor		multiple interactions	EXP	5	149,432,854	149,492,935	RGD:6480464	CTD
G	CSF1R	colony stimulating factor 1 receptor		increases expression	EXP	5	149,432,854	149,492,935	RGD:6480464	CTD
G	CSF2	colony stimulating factor 2 (granulocyte-macrophage)		multiple interactions	EXP	5	131,409,485	131,411,863	RGD:6480464	CTD
G	CSF3	colony stimulating factor 3 (granulocyte)		multiple interactions	EXP	17	38,171,614	38,174,066	RGD:6480464	CTD
G	CSF3	colony stimulating factor 3 (granulocyte)		multiple interactions	EXP	17	38,171,614	38,174,066	RGD:6480464	CTD
G	CSF3	colony stimulating factor 3 (granulocyte)		decreases expression	EXP	17	38,171,614	38,174,066	RGD:6480464	CTD
G	CSF3R	colony stimulating factor 3 receptor (granulocyte)		increases expression	EXP	1	36,931,644	36,948,915	RGD:6480464	CTD
G	CSF3R	colony stimulating factor 3 receptor (granulocyte)		increases expression	EXP	1	36,931,644	36,948,915	RGD:6480464	CTD
G	CSN3	casein kappa		increases expression	ISO	4	71,108,333	71,117,145	RGD:6480464	CTD
G	CSNK2B	casein kinase 2, beta polypeptide		decreases expression	EXP	6	31,633,657	31,637,843	RGD:6480464	CTD
G	CSRP2	cysteine and glycine-rich protein 2		decreases expression	ISO	12	77,252,496	77,272,799	RGD:6480464	CTD
G	CSRP3	cysteine and glycine-rich protein 3 (cardiac LIM protein)		increases expression	EXP	11	19,203,577	19,232,118	RGD:6480464	CTD
G	CST6	cystatin E/M		increases expression	EXP	11	65,779,462	65,780,976	RGD:6480464	CTD
G	CSTA	cystatin A (stefin A)		increases expression	EXP	3	122,044,011	122,060,816	RGD:6480464	CTD
G	CTBP2	C-terminal binding protein 2		decreases expression	ISO	10	126,676,418	126,849,624	RGD:6480464	CTD
G	CTCF	CCCTC-binding factor (zinc finger protein)		affects expression	EXP	16	67,596,310	67,673,088	RGD:6480464	CTD
G	CTNNA1	catenin (cadherin-associated protein), alpha 1, 102kDa		decreases expression	EXP	5	138,089,107	138,270,723	RGD:6480464	CTD
G	CTNNA1	catenin (cadherin-associated protein), alpha 1, 102kDa		increases expression	ISO	5	138,089,107	138,270,723	RGD:6480464	CTD
G	CTNNA2	catenin (cadherin-associated protein), alpha 2		affects expression	ISO	2	79,740,060	80,875,993	RGD:6480464	CTD
G	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa		multiple interactions	ISO	3	41,240,942	41,281,939	RGD:6480464	CTD
G	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa		increases expression	EXP	3	41,240,942	41,281,939	RGD:6480464	CTD
G	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa		increases expression	ISO	3	41,240,942	41,281,939	RGD:6480464	CTD
G	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa		decreases expression	ISO	3	41,240,942	41,281,939	RGD:6480464	CTD
G	CTNND1	catenin (cadherin-associated protein), delta 1		increases expression	ISO	11	57,529,234	57,586,652	RGD:6480464	CTD
G	CTPS1	CTP synthase 1		decreases expression	EXP	1	41,445,007	41,478,235	RGD:6480464	CTD
G	CTSD	cathepsin D		increases expression	EXP	11	1,773,982	1,785,222	RGD:6480464	CTD
G	CTSG	cathepsin G		decreases expression	EXP	14	25,042,724	25,045,466	RGD:6480464	CTD
G	CTSG	cathepsin G		decreases expression	ISO	14	25,042,724	25,045,466	RGD:6480464	CTD
G	CTSL1	cathepsin L1		decreases expression	EXP	9	90,340,974	90,346,384	RGD:6480464	CTD
G	CUBN	cubilin (intrinsic factor-cobalamin receptor)		increases expression	ISO	10	16,865,965	17,171,816	RGD:6480464	CTD
G	CUEDC1	CUE domain containing 1		increases expression	ISO	17	55,940,337	55,980,750	RGD:6480464	CTD
G	CUL4A	cullin 4A		decreases expression	EXP	13	113,863,086	113,919,392	RGD:6480464	CTD
G	CUL5	cullin 5		decreases expression	EXP	11	107,879,408	107,978,488	RGD:6480464	CTD
G	CXCL1	chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)		decreases expression	EXP	4	74,735,109	74,737,019	RGD:6480464	CTD
G	CYP26A1	cytochrome P450, family 26, subfamily A, polypeptide 1		increases expression	ISO	10	94,833,232	94,837,641	RGD:6480464	CTD
G	CYP26A1	cytochrome P450, family 26, subfamily A, polypeptide 1		increases expression	ISO	10	94,833,232	94,837,641	RGD:6480464	CTD
G	CYP26A1	cytochrome P450, family 26, subfamily A, polypeptide 1		multiple interactions	ISO	10	94,833,232	94,837,641	RGD:6480464	CTD
G	CYP26A1	cytochrome P450, family 26, subfamily A, polypeptide 1		increases expression	EXP	10	94,833,232	94,837,641	RGD:6480464	CTD
G	CYP26A1	cytochrome P450, family 26, subfamily A, polypeptide 1		multiple interactions	ISO	10	94,833,232	94,837,641	RGD:6480464	CTD
G	CYP26A1	cytochrome P450, family 26, subfamily A, polypeptide 1		increases expression	ISO	10	94,833,232	94,837,641	RGD:6480464	CTD
G	CYP26B1	cytochrome P450, family 26, subfamily B, polypeptide 1		affects degradation	EXP	2	72,356,367	72,374,963	RGD:6480464	CTD
G	CYP26B1	cytochrome P450, family 26, subfamily B, polypeptide 1		decreases activity	EXP	2	72,356,367	72,374,963	RGD:6480464	CTD
G	CYP26B1	cytochrome P450, family 26, subfamily B, polypeptide 1		increases metabolic processing	EXP	2	72,356,367	72,374,963	RGD:6480464	CTD
G	CYP26B1	cytochrome P450, family 26, subfamily B, polypeptide 1		increases expression	EXP	2	72,356,367	72,374,963	RGD:6480464	CTD
G	CYP26B1	cytochrome P450, family 26, subfamily B, polypeptide 1		multiple interactions	EXP	2	72,356,367	72,374,963	RGD:6480464	CTD
G	CYP26B1	cytochrome P450, family 26, subfamily B, polypeptide 1		multiple interactions	EXP	2	72,356,367	72,374,963	RGD:6480464	CTD
G	CYP26B1	cytochrome P450, family 26, subfamily B, polypeptide 1		increases expression	ISO	2	72,356,367	72,374,963	RGD:6480464	CTD
G	CYP26B1	cytochrome P450, family 26, subfamily B, polypeptide 1		multiple interactions	ISO	2	72,356,367	72,374,963	RGD:6480464	CTD
G	CYP26B1	cytochrome P450, family 26, subfamily B, polypeptide 1		multiple interactions	ISO	2	72,356,367	72,374,963	RGD:6480464	CTD
G	CYP26B1	cytochrome P450, family 26, subfamily B, polypeptide 1		increases expression	ISO	2	72,356,367	72,374,963	RGD:6480464	CTD
G	CYP26C1	cytochrome P450, family 26, subfamily C, polypeptide 1		decreases expression	ISO	10	94,821,021	94,828,454	RGD:6480464	CTD
G	CYP26C1	cytochrome P450, family 26, subfamily C, polypeptide 1		increases expression	ISO	10	94,821,021	94,828,454	RGD:6480464	CTD
G	CYP2C18	cytochrome P450, family 2, subfamily C, polypeptide 18		decreases expression	EXP	10	96,443,251	96,495,947	RGD:6480464	CTD
G	CYP2C19	cytochrome P450, family 2, subfamily C, polypeptide 19		decreases expression	EXP	10	96,522,463	96,612,671	RGD:6480464	CTD
G	CYP2C8	cytochrome P450, family 2, subfamily C, polypeptide 8		affects metabolic processing	EXP	10	96,796,529	96,829,254	RGD:6480464	CTD
G	CYP2C8	cytochrome P450, family 2, subfamily C, polypeptide 8		increases metabolic processing	EXP	10	96,796,529	96,829,254	RGD:6480464	CTD
G	CYP2C9	cytochrome P450, family 2, subfamily C, polypeptide 9		decreases expression	EXP	10	96,698,415	96,749,148	RGD:6480464	CTD
G	CYP2E1	cytochrome P450, family 2, subfamily E, polypeptide 1		multiple interactions	EXP	10	135,340,867	135,352,620	RGD:6480464	CTD
G	CYP2J2	cytochrome P450, family 2, subfamily J, polypeptide 2		decreases expression	EXP	1	60,358,980	60,392,423	RGD:6480464	CTD
G	CYP2J2	cytochrome P450, family 2, subfamily J, polypeptide 2		decreases expression	ISO	1	60,358,980	60,392,423	RGD:6480464	CTD
G	CYP2S1	cytochrome P450, family 2, subfamily S, polypeptide 1		multiple interactions	EXP	19	41,699,115	41,713,444	RGD:6480464	CTD
G	CYP2S1	cytochrome P450, family 2, subfamily S, polypeptide 1		affects metabolic processing	EXP	19	41,699,115	41,713,444	RGD:6480464	CTD
G	CYP2S1	cytochrome P450, family 2, subfamily S, polypeptide 1		increases expression	EXP	19	41,699,115	41,713,444	RGD:6480464	CTD
G	CYP2S1	cytochrome P450, family 2, subfamily S, polypeptide 1		affects expression	ISO	19	41,699,115	41,713,444	RGD:6480464	CTD
G	CYP2U1	cytochrome P450, family 2, subfamily U, polypeptide 1		increases expression	EXP	4	108,852,717	108,874,613	RGD:6480464	CTD
G	CYP2W1	cytochrome P450, family 2, subfamily W, polypeptide 1		decreases expression	EXP	7	1,022,835	1,029,276	RGD:6480464	CTD
G	CYP3A4	cytochrome P450, family 3, subfamily A, polypeptide 4		multiple interactions	EXP	7	99,354,583	99,381,811	RGD:6480464	CTD
G	CYP3A4	cytochrome P450, family 3, subfamily A, polypeptide 4		increases activity	EXP	7	99,354,583	99,381,811	RGD:6480464	CTD
G	CYP3A4	cytochrome P450, family 3, subfamily A, polypeptide 4		decreases expression	EXP	7	99,354,583	99,381,811	RGD:6480464	CTD
G	CYP3A7	cytochrome P450, family 3, subfamily A, polypeptide 7		affects metabolic processing	EXP	7	99,302,660	99,332,819	RGD:6480464	CTD
G	CYP3A7	cytochrome P450, family 3, subfamily A, polypeptide 7		decreases expression	EXP	7	99,302,660	99,332,819	RGD:6480464	CTD
G	CYP4A11	cytochrome P450, family 4, subfamily A, polypeptide 11		multiple interactions	EXP	1	47,394,846	47,407,156	RGD:6480464	CTD
G	CYP4A11	cytochrome P450, family 4, subfamily A, polypeptide 11		decreases expression	EXP	1	47,394,846	47,407,156	RGD:6480464	CTD
G	CYP4A11	cytochrome P450, family 4, subfamily A, polypeptide 11		decreases expression	EXP	1	47,394,846	47,407,156	RGD:6480464	CTD
G	CYP4B1	cytochrome P450, family 4, subfamily B, polypeptide 1		increases expression	EXP	1	47,264,670	47,285,021	RGD:6480464	CTD
G	CYP4B1	cytochrome P450, family 4, subfamily B, polypeptide 1		decreases expression	EXP	1	47,264,670	47,285,021	RGD:6480464	CTD
G	CYP4F3	cytochrome P450, family 4, subfamily F, polypeptide 3		increases expression	EXP	19	15,751,707	15,771,570	RGD:6480464	CTD
G	CYTL1	cytokine-like 1		decreases expression	EXP	4	5,016,313	5,021,197	RGD:6480464	CTD
G	DAB2	Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)		increases expression	ISO	5	39,371,776	39,425,335	RGD:6480464	CTD
G	DAB2	Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)		increases expression	EXP	5	39,371,776	39,425,335	RGD:6480464	CTD
G	DAG1	dystroglycan 1 (dystrophin-associated glycoprotein 1)		decreases expression	EXP	3	49,506,136	49,573,051	RGD:6480464	CTD
G	DAG1	dystroglycan 1 (dystrophin-associated glycoprotein 1)		increases expression	ISO	3	49,506,136	49,573,051	RGD:6480464	CTD
G	DAP	death-associated protein		increases expression	ISO	5	10,679,342	10,761,387	RGD:6480464	CTD
G	DAPK1	death-associated protein kinase 1		increases expression	EXP	9	90,112,756	90,323,549	RGD:6480464	CTD
G	DAPK1	death-associated protein kinase 1		affects expression	ISO	9	90,112,756	90,323,549	RGD:6480464	CTD
G	DAXX	death-domain associated protein		multiple interactions	EXP	6	33,286,335	33,290,793	RGD:6480464	CTD
G	DAZL	deleted in azoospermia-like		increases expression	ISO	3	16,628,299	16,647,006	RGD:6480464	CTD
G	DCK	deoxycytidine kinase		decreases expression	EXP	4	71,859,265	71,896,631	RGD:6480464	CTD
G	DCX	doublecortin		increases expression	EXP	X	110,537,007	110,655,460	RGD:6480464	CTD
G	DDAH2	dimethylarginine dimethylaminohydrolase 2		multiple interactions	ISO	6	31,694,817	31,698,039	RGD:6480464	CTD
G	DDAH2	dimethylarginine dimethylaminohydrolase 2		decreases expression	EXP	6	31,694,817	31,698,039	RGD:6480464	CTD
G	DDC	dopa decarboxylase (aromatic L-amino acid decarboxylase)		increases expression	ISO	7	50,526,134	50,633,154	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		increases expression	EXP	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		multiple interactions	EXP	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		increases expression	EXP	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		increases expression	ISO	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT4	DNA-damage-inducible transcript 4		increases expression	EXP	10	74,033,677	74,035,797	RGD:6480464	CTD
G	DDX10	DEAD (Asp-Glu-Ala-Asp) box polypeptide 10		decreases expression	EXP	11	108,535,816	108,811,650	RGD:6480464	CTD
G	DDX10	DEAD (Asp-Glu-Ala-Asp) box polypeptide 10		multiple interactions	EXP	11	108,535,816	108,811,650	RGD:6480464	CTD
G	DDX17	DEAD (Asp-Glu-Ala-Asp) box helicase 17		decreases expression	EXP	22	38,879,443	38,902,345	RGD:6480464	CTD
G	DDX17	DEAD (Asp-Glu-Ala-Asp) box helicase 17		decreases expression	ISO	22	38,879,443	38,902,345	RGD:6480464	CTD
G	DDX18	DEAD (Asp-Glu-Ala-Asp) box polypeptide 18		multiple interactions	EXP	2	118,572,255	118,589,953	RGD:6480464	CTD
G	DDX18	DEAD (Asp-Glu-Ala-Asp) box polypeptide 18		decreases expression	EXP	2	118,572,255	118,589,953	RGD:6480464	CTD
G	DDX21	DEAD (Asp-Glu-Ala-Asp) box helicase 21		decreases expression	EXP	10	70,715,879	70,744,825	RGD:6480464	CTD
G	DDX21	DEAD (Asp-Glu-Ala-Asp) box helicase 21		decreases expression	ISO	10	70,715,879	70,744,825	RGD:6480464	CTD
G	DDX39A	DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A		decreases expression	EXP	19	14,519,610	14,530,195	RGD:6480464	CTD
G	DDX58	DEAD (Asp-Glu-Ala-Asp) box polypeptide 58		multiple interactions	EXP	9	32,455,300	32,526,322	RGD:6480464	CTD
G	DDX58	DEAD (Asp-Glu-Ala-Asp) box polypeptide 58		increases expression	EXP	9	32,455,300	32,526,322	RGD:6480464	CTD
G	DDX58	DEAD (Asp-Glu-Ala-Asp) box polypeptide 58		decreases expression	ISO	9	32,455,300	32,526,322	RGD:6480464	CTD
G	DDX6	DEAD (Asp-Glu-Ala-Asp) box helicase 6		decreases expression	ISO	11	118,618,472	118,661,972	RGD:6480464	CTD
G	DEFA1	defensin, alpha 1		increases expression	EXP	8	6,835,171	6,837,614	RGD:6480464	CTD
G	DEFA3	defensin, alpha 3, neutrophil-specific		increases expression	EXP	8	6,873,391	6,875,816	RGD:6480464	CTD
G	DEFA3	defensin, alpha 3, neutrophil-specific		increases expression	EXP	8	6,873,391	6,875,816	RGD:6480464	CTD
G	DEFA4	defensin, alpha 4, corticostatin		increases expression	EXP	8	6,793,345	6,795,786	RGD:6480464	CTD
G	DEGS1	delta(4)-desaturase, sphingolipid 1		decreases expression	EXP	1	224,370,910	224,381,143	RGD:6480464	CTD
G	DEGS1	delta(4)-desaturase, sphingolipid 1		decreases expression	ISO	1	224,370,910	224,381,143	RGD:6480464	CTD
G	DOK4	docking protein 4		increases expression	ISO	16	57,505,870	57,520,385	RGD:6480464	CTD
G	DPYSL2	dihydropyrimidinase-like 2		multiple interactions	EXP	8	26,371,709	26,515,693	RGD:6480464	CTD
G	DPYSL2	dihydropyrimidinase-like 2		decreases expression	EXP	8	26,371,709	26,515,693	RGD:6480464	CTD
G	DRAP1	DR1-associated protein 1 (negative cofactor 2 alpha)		increases expression	EXP	11	65,686,728	65,689,048	RGD:6480464	CTD
G	DSC1	desmocollin 1		decreases expression	EXP	18	28,709,199	28,742,819	RGD:6480464	CTD
G	DSC2	desmocollin 2		increases expression	ISO	18	28,645,942	28,682,388	RGD:6480464	CTD
G	DSG2	desmoglein 2		increases expression	ISO	18	29,078,027	29,128,814	RGD:6480464	CTD
G	DSP	desmoplakin		increases expression	ISO	6	7,541,870	7,586,946	RGD:6480464	CTD
G	DSTN	destrin (actin depolymerizing factor)		decreases expression	ISO	20	17,550,599	17,588,652	RGD:6480464	CTD
G	DUOX1	dual oxidase 1		increases expression	EXP	15	45,422,192	45,457,774	RGD:6480464	CTD
G	DUSP1	dual specificity phosphatase 1		increases expression	EXP	5	172,195,093	172,198,203	RGD:6480464	CTD
G	DUSP1	dual specificity phosphatase 1		increases expression	ISO	5	172,195,093	172,198,203	RGD:6480464	CTD
G	DUSP10	dual specificity phosphatase 10		increases expression	EXP	1	221,874,764	221,915,516	RGD:6480464	CTD
G	DUSP11	dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)		decreases expression	EXP	2	73,989,325	74,007,284	RGD:6480464	CTD
G	DUSP6	dual specificity phosphatase 6		increases expression	EXP	12	89,741,837	89,746,296	RGD:6480464	CTD
G	DYNLL1	dynein, light chain, LC8-type 1		increases expression	EXP	12	120,907,660	120,936,298	RGD:6480464	CTD
G	DYSF	dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive)		increases expression	EXP	2	71,680,753	71,913,893	RGD:6480464	CTD
G	E2F1	E2F transcription factor 1		multiple interactions	EXP	20	32,263,292	32,274,210	RGD:6480464	CTD
G	E2F1	E2F transcription factor 1		decreases expression	EXP	20	32,263,292	32,274,210	RGD:6480464	CTD
G	E2F1	E2F transcription factor 1		decreases expression	EXP	20	32,263,292	32,274,210	RGD:6480464	CTD
G	E2F1	E2F transcription factor 1		increases expression	EXP	20	32,263,292	32,274,210	RGD:6480464	CTD
G	E2F4	E2F transcription factor 4, p107/p130-binding		increases expression	EXP	16	67,226,068	67,232,821	RGD:6480464	CTD
G	EBNA1BP2	EBNA1 binding protein 2		decreases expression	EXP	1	43,629,845	43,638,241	RGD:6480464	CTD
G	ECI2	enoyl-CoA delta isomerase 2		decreases expression	EXP	6	4,115,927	4,135,831	RGD:6480464	CTD
G	EDN1	endothelin 1		multiple interactions	EXP	6	12,290,529	12,297,427	RGD:6480464	CTD
G	EDN1	endothelin 1		decreases expression	ISO	6	12,290,529	12,297,427	RGD:6480464	CTD
G	EDN1	endothelin 1		decreases expression	ISO	6	12,290,529	12,297,427	RGD:6480464	CTD
G	EDN3	endothelin 3		multiple interactions	EXP	20	57,875,499	57,901,047	RGD:6480464	CTD
G	EEF1A1	eukaryotic translation elongation factor 1 alpha 1		multiple interactions	EXP	6	74,225,473	74,230,755	RGD:6480464	CTD
G	EEF1A1	eukaryotic translation elongation factor 1 alpha 1		increases expression	EXP	6	74,225,473	74,230,755	RGD:6480464	CTD
G	EEF1A1	eukaryotic translation elongation factor 1 alpha 1		increases expression	EXP	6	74,225,473	74,230,755	RGD:6480464	CTD
G	EEF1A2	eukaryotic translation elongation factor 1 alpha 2		decreases expression	EXP	20	62,119,365	62,130,668	RGD:6480464	CTD
G	EEF1G	eukaryotic translation elongation factor 1 gamma		decreases expression	EXP	11	62,327,073	62,341,460	RGD:6480464	CTD
G	EFNB1	ephrin-B1		increases expression	ISO	X	68,048,840	68,062,007	RGD:6480464	CTD
G	EFNB2	ephrin-B2		increases expression	EXP	13	107,142,079	107,187,388	RGD:6480464	CTD
G	EFNB2	ephrin-B2		multiple interactions	EXP	13	107,142,079	107,187,388	RGD:6480464	CTD
G	EGF	epidermal growth factor		decreases activity	EXP	4	110,834,040	110,934,118	RGD:6480464	CTD
G	EGF	epidermal growth factor		multiple interactions	EXP	4	110,834,040	110,934,118	RGD:6480464	CTD
G	EGF	epidermal growth factor		multiple interactions	ISO	4	110,834,040	110,934,118	RGD:6480464	CTD
G	EGFR	epidermal growth factor receptor		decreases expression	EXP	7	55,086,725	55,275,031	RGD:6480464	CTD
G	EGFR	epidermal growth factor receptor		decreases expression	EXP	7	55,086,725	55,275,031	RGD:6480464	CTD
G	EGFR	epidermal growth factor receptor		multiple interactions	ISO	7	55,086,725	55,275,031	RGD:6480464	CTD
G	EGFR	epidermal growth factor receptor		increases expression	ISO	7	55,086,725	55,275,031	RGD:6480464	CTD
G	EGFR	epidermal growth factor receptor		increases phosphorylation	ISO	7	55,086,725	55,275,031	RGD:6480464	CTD
G	EGR1	early growth response 1		increases expression	EXP	5	137,801,181	137,805,004	RGD:6480464	CTD
G	EGR1	early growth response 1		multiple interactions	ISO	5	137,801,181	137,805,004	RGD:6480464	CTD
G	EHD1	EH-domain containing 1		increases expression	EXP	11	64,620,208	64,646,191	RGD:6480464	CTD
G	EHD2	EH-domain containing 2		increases expression	ISO	19	48,216,601	48,246,391	RGD:6480464	CTD
G	EHMT2	euchromatic histone-lysine N-methyltransferase 2		multiple interactions	ISO	6	31,847,536	31,865,464	RGD:6480464	CTD
G	EIF1AX	eukaryotic translation initiation factor 1A, X-linked		decreases expression	ISO	X	20,142,636	20,159,966	RGD:6480464	CTD
G	EIF1B	eukaryotic translation initiation factor 1B		increases expression	EXP	3	40,351,173	40,353,915	RGD:6480464	CTD
G	EIF2A	eukaryotic translation initiation factor 2A, 65kDa		decreases expression	ISO	3	150,264,574	150,303,803	RGD:6480464	CTD
G	EIF2S1	eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa		decreases expression	EXP	14	67,827,034	67,853,233	RGD:6480464	CTD
G	EIF2S3	eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa		increases expression	EXP	X	24,073,065	24,096,927	RGD:6480464	CTD
G	EIF3B	eukaryotic translation initiation factor 3, subunit B		decreases expression	EXP	7	2,394,474	2,420,380	RGD:6480464	CTD
G	EIF3B	eukaryotic translation initiation factor 3, subunit B		multiple interactions	EXP	7	2,394,474	2,420,380	RGD:6480464	CTD
G	EIF3C	eukaryotic translation initiation factor 3, subunit C		multiple interactions	EXP	16	28,699,879	28,747,051	RGD:6480464	CTD
G	EIF3C	eukaryotic translation initiation factor 3, subunit C		decreases expression	EXP	16	28,699,879	28,747,051	RGD:6480464	CTD
G	EIF4A2	eukaryotic translation initiation factor 4A2		decreases expression	ISO	3	186,501,361	186,507,686	RGD:6480464	CTD
G	EIF4E	eukaryotic translation initiation factor 4E		multiple interactions	EXP	4	99,799,607	99,851,786	RGD:6480464	CTD
G	EIF4E	eukaryotic translation initiation factor 4E		decreases expression	EXP	4	99,799,607	99,851,786	RGD:6480464	CTD
G	EIF4EBP1	eukaryotic translation initiation factor 4E binding protein 1		multiple interactions	EXP	8	37,888,020	37,917,883	RGD:6480464	CTD
G	EIF4EBP1	eukaryotic translation initiation factor 4E binding protein 1		decreases expression	EXP	8	37,888,020	37,917,883	RGD:6480464	CTD
G	EIF4EBP2	eukaryotic translation initiation factor 4E binding protein 2		decreases expression	EXP	10	72,163,861	72,188,374	RGD:6480464	CTD
G	EIF4G2	eukaryotic translation initiation factor 4 gamma, 2		multiple interactions	EXP	11	10,818,593	10,830,582	RGD:6480464	CTD
G	EIF4G2	eukaryotic translation initiation factor 4 gamma, 2		multiple interactions	EXP	11	10,818,593	10,830,582	RGD:6480464	CTD
G	EIF4G2	eukaryotic translation initiation factor 4 gamma, 2		increases expression	EXP	11	10,818,593	10,830,582	RGD:6480464	CTD
G	ELF1	E74-like factor 1 (ets domain transcription factor)		affects expression	EXP	13	41,506,055	41,593,508	RGD:6480464	CTD
G	ELF1	E74-like factor 1 (ets domain transcription factor)		increases expression	ISO	13	41,506,055	41,593,508	RGD:6480464	CTD
G	ELF2	E74-like factor 2 (ets domain transcription factor)		affects expression	EXP	4	139,978,871	140,060,606	RGD:6480464	CTD
G	ELF3	E74-like factor 3 (ets domain transcription factor, epithelial-specific )		increases expression	EXP	1	201,979,690	201,986,316	RGD:6480464	CTD
G	ELF3	E74-like factor 3 (ets domain transcription factor, epithelial-specific )		increases expression	ISO	1	201,979,690	201,986,316	RGD:6480464	CTD
G	ELF4	E74-like factor 4 (ets domain transcription factor)		increases expression	EXP	X	129,198,895	129,244,688	RGD:6480464	CTD
G	ELN	elastin		increases expression	ISO	7	73,442,427	73,484,237	RGD:6480464	CTD
G	EMP1	epithelial membrane protein 1		increases expression	EXP	12	13,349,602	13,369,708	RGD:6480464	CTD
G	EMP1	epithelial membrane protein 1		increases expression	EXP	12	13,349,602	13,369,708	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		multiple interactions	EXP	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		multiple interactions	EXP	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		decreases expression	EXP	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		decreases expression	EXP	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		increases expression	EXP	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		increases expression	EXP	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		multiple interactions	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		decreases expression	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASN	fatty acid synthase		increases expression	EXP	17	80,036,214	80,056,106	RGD:6480464	CTD
G	FASN	fatty acid synthase		decreases expression	EXP	17	80,036,214	80,056,106	RGD:6480464	CTD
G	FASTK	Fas-activated serine/threonine kinase		decreases expression	EXP	7	150,773,708	150,777,970	RGD:6480464	CTD
G	FBLN1	fibulin 1		increases expression	ISO	22	45,898,719	45,997,014	RGD:6480464	CTD
G	FBP1	fructose-1,6-bisphosphatase 1		increases expression	ISO	9	97,365,415	97,402,531	RGD:6480464	CTD
G	FBP2	fructose-1,6-bisphosphatase 2		increases expression	ISO	9	97,321,002	97,356,075	RGD:6480464	CTD
G	FCER1G	Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide		increases expression	EXP	1	161,185,087	161,189,038	RGD:6480464	CTD
G	FCER2	Fc fragment of IgE, low affinity II, receptor for (CD23)		increases expression	EXP	19	7,753,643	7,767,032	RGD:6480464	CTD
G	FCGR3A	Fc fragment of IgG, low affinity IIIa, receptor (CD16a)		increases expression	EXP	1	161,511,549	161,520,413	RGD:6480464	CTD
G	FCGRT	Fc fragment of IgG, receptor, transporter, alpha		increases expression	EXP	19	50,015,536	50,029,685	RGD:6480464	CTD
G	FEN1	flap structure-specific endonuclease 1		decreases expression	EXP	11	61,560,109	61,564,716	RGD:6480464	CTD
G	FGF1	fibroblast growth factor 1 (acidic)		decreases expression	EXP	5	141,971,743	142,077,635	RGD:6480464	CTD
G	FGF10	fibroblast growth factor 10		affects expression	ISO	5	44,305,097	44,388,784	RGD:6480464	CTD
G	FGF10	fibroblast growth factor 10		increases expression	ISO	5	44,305,097	44,388,784	RGD:6480464	CTD
G	FGF10	fibroblast growth factor 10		increases expression	ISO	5	44,305,097	44,388,784	RGD:6480464	CTD
G	FGF12	fibroblast growth factor 12		decreases expression	EXP	3	191,857,182	192,445,388	RGD:6480464	CTD
G	FGF17	fibroblast growth factor 17		decreases expression	ISO	8	21,900,428	21,906,320	RGD:6480464	CTD
G	FGF2	fibroblast growth factor 2 (basic)		multiple interactions	ISO	4	123,747,863	123,819,390	RGD:6480464	CTD
G	FGF2	fibroblast growth factor 2 (basic)		decreases response to substance	ISO	4	123,747,863	123,819,390	RGD:6480464	CTD
G	FGF2	fibroblast growth factor 2 (basic)		multiple interactions	ISO	4	123,747,863	123,819,390	RGD:6480464	CTD
G	FGF2	fibroblast growth factor 2 (basic)		decreases response to substance	ISO	4	123,747,863	123,819,390	RGD:6480464	CTD
G	FGF3	fibroblast growth factor 3		affects localization	ISO	11	69,624,736	69,634,192	RGD:6480464	CTD
G	FGF3	fibroblast growth factor 3		affects expression	ISO	11	69,624,736	69,634,192	RGD:6480464	CTD
G	FGF4	fibroblast growth factor 4		multiple interactions	ISO	11	69,587,797	69,590,171	RGD:6480464	CTD
G	FGF8	fibroblast growth factor 8 (androgen-induced)		multiple interactions	EXP	10	103,529,887	103,540,126	RGD:6480464	CTD
G	FGF8	fibroblast growth factor 8 (androgen-induced)		multiple interactions	ISO	10	103,529,887	103,540,126	RGD:6480464	CTD
G	FGF8	fibroblast growth factor 8 (androgen-induced)		decreases expression	ISO	10	103,529,887	103,540,126	RGD:6480464	CTD
G	FGF8	fibroblast growth factor 8 (androgen-induced)		decreases expression	ISO	10	103,529,887	103,540,126	RGD:6480464	CTD
G	FGF9	fibroblast growth factor 9 (glia-activating factor)		increases expression	ISO	13	22,245,215	22,278,640	RGD:6480464	CTD
G	FGFBP1	fibroblast growth factor binding protein 1		decreases expression	ISO	4	15,937,192	15,940,363	RGD:6480464	CTD
G	FGFR1	fibroblast growth factor receptor 1		increases expression	ISO	8	38,268,656	38,326,352	RGD:6480464	CTD
G	FGFR1	fibroblast growth factor receptor 1		increases expression	ISO	8	38,268,656	38,326,352	RGD:6480464	CTD
G	FGFR2	fibroblast growth factor receptor 2		decreases expression	EXP	10	123,237,844	123,357,972	RGD:6480464	CTD
G	FGFR2	fibroblast growth factor receptor 2		decreases expression	ISO	10	123,237,844	123,357,972	RGD:6480464	CTD
G	FGFR3	fibroblast growth factor receptor 3		decreases expression	EXP	4	1,795,039	1,810,599	RGD:6480464	CTD
G	FGFR4	fibroblast growth factor receptor 4		decreases expression	EXP	5	176,513,921	176,525,127	RGD:6480464	CTD
G	FGR	Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog		increases expression	EXP	1	27,938,800	27,961,727	RGD:6480464	CTD
G	FHL5	four and a half LIM domains 5		increases expression	ISO	6	97,010,424	97,064,512	RGD:6480464	CTD
G	FKBP8	FK506 binding protein 8, 38kDa		decreases expression	EXP	19	18,642,568	18,654,383	RGD:6480464	CTD
G	FLG	filaggrin		increases expression	EXP	1	152,274,651	152,297,679	RGD:6480464	CTD
G	FLG	filaggrin		decreases expression	EXP	1	152,274,651	152,297,679	RGD:6480464	CTD
G	FLI1	Friend leukemia virus integration 1		increases expression	ISO	11	128,556,430	128,683,162	RGD:6480464	CTD
G	FLNB	filamin B, beta		increases expression	EXP	3	57,994,127	58,157,982	RGD:6480464	CTD
G	FLT3	fms-related tyrosine kinase 3		multiple interactions	EXP	13	28,577,411	28,674,729	RGD:6480464	CTD
G	FLT3	fms-related tyrosine kinase 3		increases response to substance	EXP	13	28,577,411	28,674,729	RGD:6480464	CTD
G	FN1	fibronectin 1		multiple interactions	EXP	2	216,225,177	216,300,791	RGD:6480464	CTD
G	FN1	fibronectin 1		increases expression	EXP	2	216,225,177	216,300,791	RGD:6480464	CTD
G	FN1	fibronectin 1		multiple interactions	ISO	2	216,225,177	216,300,791	RGD:6480464	CTD
G	FNDC7	fibronectin type III domain containing 7		decreases expression	ISO	1	109,255,556	109,285,371	RGD:6480464	CTD
G	FOLR1	folate receptor 1 (adult)		increases expression	ISO	11	71,900,602	71,907,367	RGD:6480464	CTD
G	FOLR2	folate receptor 2 (fetal)		multiple interactions	EXP	11	71,927,819	71,932,994	RGD:6480464	CTD
G	FOLR2	folate receptor 2 (fetal)		increases expression	EXP	11	71,927,819	71,932,994	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		decreases expression	EXP	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		decreases expression	ISO	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		increases expression	EXP	14	75,745,481	75,748,937	RGD:6480464	CTD
G	GDNF	glial cell derived neurotrophic factor		decreases expression	ISO	5	37,812,779	37,839,782	RGD:6480464	CTD
G	GDNF	glial cell derived neurotrophic factor		increases secretion	EXP	5	37,812,779	37,839,782	RGD:6480464	CTD
G	GDNF	glial cell derived neurotrophic factor		multiple interactions	ISO	5	37,812,779	37,839,782	RGD:6480464	CTD
G	GDPD5	glycerophosphodiester phosphodiesterase domain containing 5		increases expression	ISO	11	75,145,685	75,236,599	RGD:6480464	CTD
G	GFAP	glial fibrillary acidic protein		multiple interactions	EXP	17	42,982,994	42,992,920	RGD:6480464	CTD
G	GFAP	glial fibrillary acidic protein		increases expression	EXP	17	42,982,994	42,992,920	RGD:6480464	CTD
G	GFAP	glial fibrillary acidic protein		decreases expression	ISO	17	42,982,994	42,992,920	RGD:6480464	CTD
G	GFI1	growth factor independent 1 transcription repressor		decreases expression	EXP	1	92,940,318	92,952,433	RGD:6480464	CTD
G	GFRA1	GDNF family receptor alpha 1		multiple interactions	EXP	10	117,816,436	118,033,126	RGD:6480464	CTD
G	GFRA1	GDNF family receptor alpha 1		multiple interactions	EXP	10	117,816,436	118,033,126	RGD:6480464	CTD
G	GFRA1	GDNF family receptor alpha 1		increases expression	ISO	10	117,816,436	118,033,126	RGD:6480464	CTD
G	GFRA1	GDNF family receptor alpha 1		decreases expression	ISO	10	117,816,436	118,033,126	RGD:6480464	CTD
G	GFRA2	GDNF family receptor alpha 2		affects expression	ISO	8	21,549,530	21,646,346	RGD:6480464	CTD
G	GGT1	gamma-glutamyltransferase 1		increases expression	ISO	22	24,979,718	25,024,972	RGD:6480464	CTD
G	GGT2	gamma-glutamyltransferase 2		increases expression	EXP	22	21,562,427	21,580,490	RGD:6480464	CTD
G	GH1	growth hormone 1		affects expression	ISO	17	61,994,563	61,996,198	RGD:6480464	CTD
G	GH1	growth hormone 1		increases expression	ISO	17	61,994,563	61,996,198	RGD:6480464	CTD
G	GHRH	growth hormone releasing hormone		multiple interactions	ISO	20	35,879,489	35,885,299	RGD:6480464	CTD
G	GINS1	GINS complex subunit 1 (Psf1 homolog)		decreases expression	EXP	20	25,388,323	25,429,191	RGD:6480464	CTD
G	GINS2	GINS complex subunit 2 (Psf2 homolog)		decreases expression	EXP	16	85,711,280	85,722,588	RGD:6480464	CTD
G	GJA1	gap junction protein, alpha 1, 43kDa		increases expression	EXP	6	121,756,745	121,770,873	RGD:6480464	CTD
G	GJB1	gap junction protein, beta 1, 32kDa		increases expression	EXP	X	70,435,062	70,445,065	RGD:6480464	CTD
G	GJB2	gap junction protein, beta 2, 26kDa		increases expression	EXP	13	20,761,602	20,767,114	RGD:6480464	CTD
G	GJB5	gap junction protein, beta 5, 31.1kDa		decreases expression	ISO	1	35,220,721	35,224,112	RGD:6480464	CTD
G	GLI1	GLI family zinc finger 1		multiple interactions	EXP	12	57,853,918	57,866,051	RGD:6480464	CTD
G	GLRX3	glutaredoxin 3		decreases expression	ISO	10	131,934,639	131,978,646	RGD:6480464	CTD
G	GLUD1	glutamate dehydrogenase 1		multiple interactions	EXP	10	88,809,959	88,854,776	RGD:6480464	CTD
G	GLUD1	glutamate dehydrogenase 1		decreases expression	EXP	10	88,809,959	88,854,776	RGD:6480464	CTD
G	GLUL	glutamate-ammonia ligase		increases expression	EXP	1	182,350,839	182,361,341	RGD:6480464	CTD
G	GNA13	guanine nucleotide binding protein (G protein), alpha 13		multiple interactions	ISO	17	63,005,407	63,052,920	RGD:6480464	CTD
G	GNA13	guanine nucleotide binding protein (G protein), alpha 13		increases expression	ISO	17	63,005,407	63,052,920	RGD:6480464	CTD
G	GNAT1	guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1		increases expression	EXP	3	50,229,043	50,235,129	RGD:6480464	CTD
G	GNL3	guanine nucleotide binding protein-like 3 (nucleolar)		decreases expression	ISO	3	52,719,936	52,728,513	RGD:6480464	CTD
G	GNPNAT1	glucosamine-phosphate N-acetyltransferase 1		decreases expression	ISO	14	53,241,911	53,258,386	RGD:6480464	CTD
G	GNS	glucosamine (N-acetyl)-6-sulfatase		increases expression	EXP	12	65,107,222	65,153,226	RGD:6480464	CTD
G	GPD1	glycerol-3-phosphate dehydrogenase 1 (soluble)		decreases expression	ISO	12	50,497,602	50,505,103	RGD:6480464	CTD
G	GPNMB	glycoprotein (transmembrane) nmb		increases expression	EXP	7	23,286,316	23,314,729	RGD:6480464	CTD
G	GPR137B	G protein-coupled receptor 137B		increases expression	EXP	1	236,305,832	236,372,209	RGD:6480464	CTD
G	GPRC5A	G protein-coupled receptor, family C, group 5, member A		increases expression	EXP	12	13,043,956	13,066,600	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		decreases expression	EXP	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		increases expression	EXP	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GPX2	glutathione peroxidase 2 (gastrointestinal)		multiple interactions	EXP	14	65,405,870	65,409,623	RGD:6480464	CTD
G	GPX2	glutathione peroxidase 2 (gastrointestinal)		increases activity	EXP	14	65,405,870	65,409,623	RGD:6480464	CTD
G	GPX2	glutathione peroxidase 2 (gastrointestinal)		increases expression	EXP	14	65,405,870	65,409,623	RGD:6480464	CTD
G	GPX4	glutathione peroxidase 4		decreases activity	ISO	19	1,103,936	1,106,787	RGD:6480464	CTD
G	GRB10	growth factor receptor-bound protein 10		decreases expression	EXP	7	50,657,760	50,861,159	RGD:6480464	CTD
G	GRB10	growth factor receptor-bound protein 10		multiple interactions	EXP	7	50,657,760	50,861,159	RGD:6480464	CTD
G	GRB7	growth factor receptor-bound protein 7		decreases expression	EXP	17	37,894,162	37,903,538	RGD:6480464	CTD
G	GREB1L	growth regulation by estrogen in breast cancer-like		increases expression	ISO	18	18,822,203	19,102,791	RGD:6480464	CTD
G	GRIA2	glutamate receptor, ionotropic, AMPA 2		decreases expression	ISO	4	158,141,736	158,287,227	RGD:6480464	CTD
G	GRID1	glutamate receptor, ionotropic, delta 1		decreases expression	ISO	10	87,359,312	88,126,250	RGD:6480464	CTD
G	GRIK5	glutamate receptor, ionotropic, kainate 5		decreases expression	ISO	19	42,502,468	42,569,957	RGD:6480464	CTD
G	GRIN2B	glutamate receptor, ionotropic, N-methyl D-aspartate 2B		increases expression	EXP	12	13,714,410	14,133,022	RGD:6480464	CTD
G	GRN	granulin		affects expression	EXP	17	42,422,491	42,430,470	RGD:6480464	CTD
G	GRN	granulin		increases expression	EXP	17	42,422,491	42,430,470	RGD:6480464	CTD
G	GSE1	Gse1 coiled-coil protein		increases expression	ISO	16	85,645,029	85,709,812	RGD:6480464	CTD
G	GSK3A	glycogen synthase kinase 3 alpha		decreases phosphorylation	ISO	19	42,734,338	42,746,736	RGD:6480464	CTD
G	GSK3A	glycogen synthase kinase 3 alpha		increases phosphorylation	ISO	19	42,734,338	42,746,736	RGD:6480464	CTD
G	GSK3B	glycogen synthase kinase 3 beta		decreases phosphorylation	ISO	3	119,540,800	119,813,264	RGD:6480464	CTD
G	GSK3B	glycogen synthase kinase 3 beta		increases phosphorylation	ISO	3	119,540,800	119,813,264	RGD:6480464	CTD
G	GSN	gelsolin		increases expression	ISO	9	124,030,380	124,095,120	RGD:6480464	CTD
G	GSN	gelsolin		increases expression	EXP	9	124,030,380	124,095,120	RGD:6480464	CTD
G	GSR	glutathione reductase		increases expression	EXP	8	30,535,578	30,585,486	RGD:6480464	CTD
G	GSTM1	glutathione S-transferase mu 1		decreases expression	EXP	1	110,230,418	110,236,367	RGD:6480464	CTD
G	GSTM2	glutathione S-transferase mu 2 (muscle)		decreases expression	ISO	1	110,210,644	110,226,619	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		multiple interactions	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		decreases expression	ISO	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		increases expression	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GTF2A1	general transcription factor IIA, 1, 19/37kDa		decreases expression	EXP	14	81,641,796	81,687,575	RGD:6480464	CTD
G	GTF2A1L	general transcription factor IIA, 1-like		decreases expression	EXP	2	48,844,937	48,906,748	RGD:6480464	CTD
G	GTF2A2	general transcription factor IIA, 2, 12kDa		decreases expression	EXP	15	59,930,261	59,949,737	RGD:6480464	CTD
G	GTF2H3	general transcription factor IIH, polypeptide 3, 34kDa		decreases expression	EXP	12	124,118,381	124,145,334	RGD:6480464	CTD
G	GTF3A	general transcription factor IIIA		increases expression	EXP	13	27,998,681	28,009,846	RGD:6480464	CTD
G	GTSE1	G-2 and S-phase expressed 1		decreases expression	EXP	22	46,692,638	46,726,707	RGD:6480464	CTD
G	GZMB	granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)		decreases expression	EXP	14	25,100,160	25,103,432	RGD:6480464	CTD
G	H19	H19, imprinted maternally expressed transcript (non-protein coding)		increases expression	ISO	11	2,016,406	2,019,065	RGD:6480464	CTD
G	HMGB2	high mobility group box 2		decreases expression	EXP	4	174,252,527	174,255,595	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		increases expression	EXP	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		decreases expression	EXP	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HMOX2	heme oxygenase (decycling) 2		multiple interactions	EXP	16	4,524,719	4,560,348	RGD:6480464	CTD
G	HNF1B	HNF1 homeobox B		increases expression	ISO	17	36,046,434	36,105,096	RGD:6480464	CTD
G	HNRNPAB	heterogeneous nuclear ribonucleoprotein A/B		multiple interactions	EXP	5	177,631,508	177,638,184	RGD:6480464	CTD
G	HNRNPAB	heterogeneous nuclear ribonucleoprotein A/B		decreases expression	EXP	5	177,631,508	177,638,184	RGD:6480464	CTD
G	HNRNPD	heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)		increases expression	ISO	4	83,274,467	83,295,149	RGD:6480464	CTD
G	HNRNPH1	heterogeneous nuclear ribonucleoprotein H1 (H)		multiple interactions	EXP	5	179,041,179	179,050,722	RGD:6480464	CTD
G	HNRNPH1	heterogeneous nuclear ribonucleoprotein H1 (H)		increases expression	EXP	5	179,041,179	179,050,722	RGD:6480464	CTD
G	HNRNPH2	heterogeneous nuclear ribonucleoprotein H2 (H')		multiple interactions	EXP	X	100,663,121	100,669,128	RGD:6480464	CTD
G	HNRNPH2	heterogeneous nuclear ribonucleoprotein H2 (H')		increases expression	EXP	X	100,663,121	100,669,128	RGD:6480464	CTD
G	HNRNPH3	heterogeneous nuclear ribonucleoprotein H3 (2H9)		multiple interactions	EXP	10	70,091,768	70,102,953	RGD:6480464	CTD
G	HNRNPH3	heterogeneous nuclear ribonucleoprotein H3 (2H9)		decreases expression	EXP	10	70,091,768	70,102,953	RGD:6480464	CTD
G	HOPX	HOP homeobox		increases expression	EXP	4	57,514,154	57,547,872	RGD:6480464	CTD
G	HOXA1	homeobox A1		increases expression	EXP	7	27,132,612	27,135,625	RGD:6480464	CTD
G	HOXA1	homeobox A1		multiple interactions	EXP	7	27,132,612	27,135,625	RGD:6480464	CTD
G	HOXA1	homeobox A1		multiple interactions	ISO	7	27,132,612	27,135,625	RGD:6480464	CTD
G	HOXA1	homeobox A1		affects expression	ISO	7	27,132,612	27,135,625	RGD:6480464	CTD
G	HOXA1	homeobox A1		increases expression	ISO	7	27,132,612	27,135,625	RGD:6480464	CTD
G	HOXA1	homeobox A1		increases expression	ISO	7	27,132,612	27,135,625	RGD:6480464	CTD
G	HOXA1	homeobox A1		increases expression	ISO	7	27,132,612	27,135,625	RGD:6480464	CTD
G	HOXA10	homeobox A10		increases expression	EXP	7	27,210,210	27,219,880	RGD:6480464	CTD
G	HOXA11	homeobox A11		decreases expression	ISO	7	27,220,776	27,224,835	RGD:6480464	CTD
G	HOXA2	homeobox A2		increases expression	EXP	7	27,139,973	27,142,394	RGD:6480464	CTD
G	HOXA3	homeobox A3		increases expression	EXP	7	27,145,809	27,166,639	RGD:6480464	CTD
G	HOXA3	homeobox A3		increases expression	ISO	7	27,145,809	27,166,639	RGD:6480464	CTD
G	HOXA4	homeobox A4		increases expression	EXP	7	27,168,126	27,170,399	RGD:6480464	CTD
G	HOXA4	homeobox A4		increases expression	ISO	7	27,168,126	27,170,399	RGD:6480464	CTD
G	HOXA5	homeobox A5		increases expression	ISO	7	27,180,671	27,183,287	RGD:6480464	CTD
G	HOXA5	homeobox A5		increases expression	ISO	7	27,180,671	27,183,287	RGD:6480464	CTD
G	HOXA6	homeobox A6		increases expression	EXP	7	27,185,202	27,187,393	RGD:6480464	CTD
G	HOXA7	homeobox A7		increases expression	EXP	7	27,193,335	27,196,296	RGD:6480464	CTD
G	HOXA7	homeobox A7		affects expression	ISO	7	27,193,335	27,196,296	RGD:6480464	CTD
G	HOXB1	homeobox B1		increases expression	ISO	17	46,606,807	46,608,272	RGD:6480464	CTD
G	HOXB13	homeobox B13		increases expression	ISO	17	46,802,125	46,806,111	RGD:6480464	CTD
G	HOXB2	homeobox B2		increases expression	ISO	17	46,620,017	46,622,393	RGD:6480464	CTD
G	HOXB3	homeobox B3		increases expression	ISO	17	46,626,232	46,651,810	RGD:6480464	CTD
G	HOXB4	homeobox B4		increases expression	ISO	17	46,652,869	46,655,743	RGD:6480464	CTD
G	HOXB5	homeobox B5		increases expression	EXP	17	46,668,619	46,671,103	RGD:6480464	CTD
G	HOXB5	homeobox B5		increases expression	ISO	17	46,668,619	46,671,103	RGD:6480464	CTD
G	HOXB6	homeobox B6		increases expression	ISO	17	46,673,099	46,682,334	RGD:6480464	CTD
G	HOXB7	homeobox B7		increases expression	ISO	17	46,684,594	46,688,383	RGD:6480464	CTD
G	HOXB8	homeobox B8		increases expression	ISO	17	46,689,708	46,692,301	RGD:6480464	CTD
G	HOXB8	homeobox B8		increases expression	EXP	17	46,689,708	46,692,301	RGD:6480464	CTD
G	HOXB9	homeobox B9		increases expression	EXP	17	46,698,518	46,703,835	RGD:6480464	CTD
G	HOXB9	homeobox B9		increases expression	ISO	17	46,698,518	46,703,835	RGD:6480464	CTD
G	HOXC10	homeobox C10		increases expression	ISO	12	54,378,946	54,384,063	RGD:6480464	CTD
G	HOXC4	homeobox C4		increases expression	EXP	12	54,410,642	54,449,814	RGD:6480464	CTD
G	HOXC4	homeobox C4		multiple interactions	EXP	12	54,410,642	54,449,814	RGD:6480464	CTD
G	HOXC4	homeobox C4		increases expression	ISO	12	54,410,642	54,449,814	RGD:6480464	CTD
G	HOXD1	homeobox D1		increases expression	ISO	2	177,053,307	177,055,635	RGD:6480464	CTD
G	HOXD12	homeobox D12		decreases expression	ISO	2	176,964,530	176,965,488	RGD:6480464	CTD
G	HOXD4	homeobox D4		increases expression	ISO	2	177,016,113	177,017,951	RGD:6480464	CTD
G	HOXD4	homeobox D4		multiple interactions	ISO	2	177,016,113	177,017,951	RGD:6480464	CTD
G	HOXD8	homeobox D8		decreases expression	ISO	2	176,994,422	176,997,423	RGD:6480464	CTD
G	HPVC1	human papillomavirus (type 18) E5 central sequence-like 1		decreases expression	ISO	7	54,268,917	54,270,114	RGD:6480464	CTD
G	HRAS	v-Ha-ras Harvey rat sarcoma viral oncogene homolog		decreases expression	ISO	11	532,242	535,550	RGD:6480464	CTD
G	HSD17B1	hydroxysteroid (17-beta) dehydrogenase 1		increases expression	EXP	17	40,703,984	40,707,232	RGD:6480464	CTD
G	HSD17B1	hydroxysteroid (17-beta) dehydrogenase 1		increases activity	EXP	17	40,703,984	40,707,232	RGD:6480464	CTD
G	HSD17B11	hydroxysteroid (17-beta) dehydrogenase 11		decreases expression	ISO	4	88,257,691	88,312,455	RGD:6480464	CTD
G	HSD17B2	hydroxysteroid (17-beta) dehydrogenase 2		increases expression	EXP	16	82,068,858	82,132,139	RGD:6480464	CTD
G	HSP90AB1	heat shock protein 90kDa alpha (cytosolic), class B member 1		decreases expression	EXP	6	44,214,849	44,221,614	RGD:6480464	CTD
G	HSPA5	heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)		multiple interactions	EXP	9	127,997,127	128,003,666	RGD:6480464	CTD
G	HSPA5	heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)		increases expression	EXP	9	127,997,127	128,003,666	RGD:6480464	CTD
G	HSPA8	heat shock 70kDa protein 8		decreases expression	EXP	11	122,928,200	122,932,901	RGD:6480464	CTD
G	HSPD1	heat shock 60kDa protein 1 (chaperonin)		decreases expression	EXP	2	198,351,308	198,364,998	RGD:6480464	CTD
G	HSPE1	heat shock 10kDa protein 1 (chaperonin 10)		decreases expression	EXP	2	198,364,721	198,368,187	RGD:6480464	CTD
G	HSPG2	heparan sulfate proteoglycan 2		increases expression	EXP	1	22,148,737	22,263,750	RGD:6480464	CTD
G	HTATSF1	HIV-1 Tat specific factor 1		increases expression	ISO	X	135,579,238	135,594,505	RGD:6480464	CTD
G	IBSP	integrin-binding sialoprotein		multiple interactions	ISO	4	88,720,702	88,733,601	RGD:6480464	CTD
G	ICAM1	intercellular adhesion molecule 1		multiple interactions	EXP	19	10,381,517	10,397,291	RGD:6480464	CTD
G	ICAM1	intercellular adhesion molecule 1		increases expression	EXP	19	10,381,517	10,397,291	RGD:6480464	CTD
G	ICAM1	intercellular adhesion molecule 1		decreases expression	ISO	19	10,381,517	10,397,291	RGD:6480464	CTD
G	ICAM1	intercellular adhesion molecule 1		multiple interactions	ISO	19	10,381,517	10,397,291	RGD:6480464	CTD
G	ICAM3	intercellular adhesion molecule 3		multiple interactions	EXP	19	10,444,452	10,450,345	RGD:6480464	CTD
G	ICAM3	intercellular adhesion molecule 3		increases expression	EXP	19	10,444,452	10,450,345	RGD:6480464	CTD
G	ID1	inhibitor of DNA binding 1, dominant negative helix-loop-helix protein		increases expression	EXP	20	30,193,086	30,194,318	RGD:6480464	CTD
G	ID1	inhibitor of DNA binding 1, dominant negative helix-loop-helix protein		multiple interactions	EXP	20	30,193,086	30,194,318	RGD:6480464	CTD
G	ID1	inhibitor of DNA binding 1, dominant negative helix-loop-helix protein		increases expression	EXP	20	30,193,086	30,194,318	RGD:6480464	CTD
G	IGFBP6	insulin-like growth factor binding protein 6		decreases expression	EXP	12	53,491,436	53,496,128	RGD:6480464	CTD
G	IGFBP6	insulin-like growth factor binding protein 6		increases expression	EXP	12	53,491,436	53,496,128	RGD:6480464	CTD
G	IGSF8	immunoglobulin superfamily, member 8		increases expression	ISO	1	160,061,129	160,068,618	RGD:6480464	CTD
G	IHH	indian hedgehog		decreases expression	ISO	2	219,919,142	219,925,238	RGD:6480464	CTD
G	IL10	interleukin 10		multiple interactions	EXP	1	206,940,948	206,945,839	RGD:6480464	CTD
G	IL10	interleukin 10		multiple interactions	EXP	1	206,940,948	206,945,839	RGD:6480464	CTD
G	IL10	interleukin 10		multiple interactions	EXP	1	206,940,948	206,945,839	RGD:6480464	CTD
G	IL10	interleukin 10		increases expression	EXP	1	206,940,948	206,945,839	RGD:6480464	CTD
G	IL10	interleukin 10		increases secretion	EXP	1	206,940,948	206,945,839	RGD:6480464	CTD
G	IL10RA	interleukin 10 receptor, alpha		decreases expression	EXP	11	117,857,106	117,872,198	RGD:6480464	CTD
G	IL12A	interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)		multiple interactions	EXP	3	159,706,623	159,713,806	RGD:6480464	CTD
G	IL12A	interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)		decreases expression	EXP	3	159,706,623	159,713,806	RGD:6480464	CTD
G	IL12A	interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)		multiple interactions	EXP	3	159,706,623	159,713,806	RGD:6480464	CTD
G	IL12B	interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)		multiple interactions	EXP	5	158,741,791	158,757,481	RGD:6480464	CTD
G	IL12B	interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)		decreases expression	EXP	5	158,741,791	158,757,481	RGD:6480464	CTD
G	IL12B	interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)		multiple interactions	EXP	5	158,741,791	158,757,481	RGD:6480464	CTD
G	IL12B	interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)		multiple interactions	EXP	5	158,741,791	158,757,481	RGD:6480464	CTD
G	IL13	interleukin 13		increases expression	EXP	5	131,993,865	131,996,801	RGD:6480464	CTD
G	IL13RA2	interleukin 13 receptor, alpha 2		increases expression	EXP	X	114,238,538	114,252,207	RGD:6480464	CTD
G	IL18	interleukin 18 (interferon-gamma-inducing factor)		affects expression	ISO	11	112,013,974	112,034,840	RGD:6480464	CTD
G	IL1A	interleukin 1, alpha		multiple interactions	EXP	2	113,531,492	113,542,971	RGD:6480464	CTD
G	IL1A	interleukin 1, alpha		affects activity	ISO	2	113,531,492	113,542,971	RGD:6480464	CTD
G	IL1A	interleukin 1, alpha		multiple interactions	ISO	2	113,531,492	113,542,971	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		increases expression	EXP	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		decreases expression	EXP	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		multiple interactions	EXP	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		increases expression	EXP	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		multiple interactions	ISO	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		multiple interactions	ISO	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		decreases expression	ISO	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IL2	interleukin 2		decreases activity	EXP	4	123,372,625	123,377,650	RGD:6480464	CTD
G	IL2	interleukin 2		multiple interactions	EXP	4	123,372,625	123,377,650	RGD:6480464	CTD
G	IL2	interleukin 2		decreases expression	EXP	4	123,372,625	123,377,650	RGD:6480464	CTD
G	IL2	interleukin 2		increases expression	EXP	4	123,372,625	123,377,650	RGD:6480464	CTD
G	IL2	interleukin 2		increases expression	ISO	4	123,372,625	123,377,650	RGD:6480464	CTD
G	IL2	interleukin 2		multiple interactions	ISO	4	123,372,625	123,377,650	RGD:6480464	CTD
G	IL24	interleukin 24		decreases expression	EXP	1	207,070,788	207,077,484	RGD:6480464	CTD
G	IL3	interleukin 3 (colony-stimulating factor, multiple)		multiple interactions	EXP	5	131,396,347	131,398,896	RGD:6480464	CTD
G	IL4	interleukin 4		multiple interactions	EXP	5	132,009,678	132,018,370	RGD:6480464	CTD
G	IL4	interleukin 4		decreases activity	EXP	5	132,009,678	132,018,370	RGD:6480464	CTD
G	IL4	interleukin 4		multiple interactions	EXP	5	132,009,678	132,018,370	RGD:6480464	CTD
G	IL4	interleukin 4		increases expression	EXP	5	132,009,678	132,018,370	RGD:6480464	CTD
G	IL4	interleukin 4		increases expression	EXP	5	132,009,678	132,018,370	RGD:6480464	CTD
G	IL4	interleukin 4		increases secretion	EXP	5	132,009,678	132,018,370	RGD:6480464	CTD
G	IL4	interleukin 4		multiple interactions	ISO	5	132,009,678	132,018,370	RGD:6480464	CTD
G	IL5	interleukin 5 (colony-stimulating factor, eosinophil)		decreases activity	EXP	5	131,877,136	131,879,214	RGD:6480464	CTD
G	IL5	interleukin 5 (colony-stimulating factor, eosinophil)		multiple interactions	EXP	5	131,877,136	131,879,214	RGD:6480464	CTD
G	IL5	interleukin 5 (colony-stimulating factor, eosinophil)		increases expression	EXP	5	131,877,136	131,879,214	RGD:6480464	CTD
G	IL5	interleukin 5 (colony-stimulating factor, eosinophil)		multiple interactions	ISO	5	131,877,136	131,879,214	RGD:6480464	CTD
G	IL5RA	interleukin 5 receptor, alpha		multiple interactions	EXP	3	3,108,008	3,152,058	RGD:6480464	CTD
G	IL5RA	interleukin 5 receptor, alpha		decreases expression	EXP	3	3,108,008	3,152,058	RGD:6480464	CTD
G	IL5RA	interleukin 5 receptor, alpha		decreases expression	EXP	3	3,108,008	3,152,058	RGD:6480464	CTD
G	IL5RA	interleukin 5 receptor, alpha		decreases expression	EXP	3	3,108,008	3,152,058	RGD:6480464	CTD
G	IL5RA	interleukin 5 receptor, alpha		increases expression	EXP	3	3,108,008	3,152,058	RGD:6480464	CTD
G	IL5RA	interleukin 5 receptor, alpha		multiple interactions	ISO	3	3,108,008	3,152,058	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		decreases expression	EXP	7	22,766,766	22,771,621	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		decreases expression	EXP	7	22,766,766	22,771,621	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		increases expression	EXP	7	22,766,766	22,771,621	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		multiple interactions	ISO	7	22,766,766	22,771,621	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		multiple interactions	ISO	7	22,766,766	22,771,621	RGD:6480464	CTD
G	IL6	interleukin 6 (interferon, beta 2)		decreases expression	ISO	7	22,766,766	22,771,621	RGD:6480464	CTD
G	IL8	interleukin 8		multiple interactions	EXP	4	74,606,223	74,609,433	RGD:6480464	CTD
G	IL8	interleukin 8		multiple interactions	EXP	4	74,606,223	74,609,433	RGD:6480464	CTD
G	IL8	interleukin 8		multiple interactions	EXP	4	74,606,223	74,609,433	RGD:6480464	CTD
G	IL8	interleukin 8		increases expression	EXP	4	74,606,223	74,609,433	RGD:6480464	CTD
G	IL8	interleukin 8		increases secretion	EXP	4	74,606,223	74,609,433	RGD:6480464	CTD
G	IL8	interleukin 8		increases expression	EXP	4	74,606,223	74,609,433	RGD:6480464	CTD
G	ILF3	interleukin enhancer binding factor 3, 90kDa		decreases expression	EXP	19	10,764,937	10,803,095	RGD:6480464	CTD
G	ILKAP	integrin-linked kinase-associated serine/threonine phosphatase		decreases expression	EXP	2	239,079,043	239,112,324	RGD:6480464	CTD
G	INA	internexin neuronal intermediate filament protein, alpha		decreases expression	ISO	10	105,036,920	105,050,108	RGD:6480464	CTD
G	INHBC	inhibin, beta C		decreases expression	EXP	12	57,828,543	57,844,609	RGD:6480464	CTD
G	ITGB2	integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)		increases expression	EXP	21	46,305,868	46,348,753	RGD:6480464	CTD
G	ITGB2	integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)		increases expression	EXP	21	46,305,868	46,348,753	RGD:6480464	CTD
G	ITGB7	integrin, beta 7		increases expression	EXP	12	53,585,107	53,601,000	RGD:6480464	CTD
G	ITM2B	integral membrane protein 2B		decreases expression	ISO	13	48,807,274	48,836,232	RGD:6480464	CTD
G	ITM2B	integral membrane protein 2B		increases expression	EXP	13	48,807,274	48,836,232	RGD:6480464	CTD
G	ITPKA	inositol-trisphosphate 3-kinase A		decreases expression	ISO	15	41,786,056	41,795,757	RGD:6480464	CTD
G	IVL	involucrin		multiple interactions	EXP	1	152,881,039	152,884,362	RGD:6480464	CTD
G	IVL	involucrin		decreases expression	EXP	1	152,881,039	152,884,362	RGD:6480464	CTD
G	IVL	involucrin		increases expression	EXP	1	152,881,039	152,884,362	RGD:6480464	CTD
G	IVL	involucrin		increases expression	EXP	1	152,881,039	152,884,362	RGD:6480464	CTD
G	JUN	jun proto-oncogene		multiple interactions	EXP	1	59,246,463	59,249,785	RGD:6480464	CTD
G	JUN	jun proto-oncogene		multiple interactions	EXP	1	59,246,463	59,249,785	RGD:6480464	CTD
G	JUN	jun proto-oncogene		multiple interactions	EXP	1	59,246,463	59,249,785	RGD:6480464	CTD
G	JUN	jun proto-oncogene		decreases expression	EXP	1	59,246,463	59,249,785	RGD:6480464	CTD
G	JUN	jun proto-oncogene		decreases phosphorylation	EXP	1	59,246,463	59,249,785	RGD:6480464	CTD
G	JUN	jun proto-oncogene		increases phosphorylation	EXP	1	59,246,463	59,249,785	RGD:6480464	CTD
G	JUN	jun proto-oncogene		affects expression	ISO	1	59,246,463	59,249,785	RGD:6480464	CTD
G	JUN	jun proto-oncogene		increases expression	ISO	1	59,246,463	59,249,785	RGD:6480464	CTD
G	JUN	jun proto-oncogene		decreases expression	ISO	1	59,246,463	59,249,785	RGD:6480464	CTD
G	JUNB	jun B proto-oncogene		increases expression	EXP	19	12,902,310	12,904,125	RGD:6480464	CTD
G	JUND	jun D proto-oncogene		increases expression	EXP	19	18,390,563	18,392,432	RGD:6480464	CTD
G	JUND	jun D proto-oncogene		increases expression	ISO	19	18,390,563	18,392,432	RGD:6480464	CTD
G	KCNB1	potassium voltage-gated channel, Shab-related subfamily, member 1		multiple interactions	EXP	20	47,988,505	48,099,181	RGD:6480464	CTD
G	KDELR3	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3		increases expression	EXP	22	38,864,083	38,879,445	RGD:6480464	CTD
G	KDM1A	lysine (K)-specific demethylase 1A		affects localization	EXP	1	23,345,941	23,410,184	RGD:6480464	CTD
G	KDM4B	lysine (K)-specific demethylase 4B		affects expression	ISO	19	4,969,124	5,153,609	RGD:6480464	CTD
G	KDM5B	lysine (K)-specific demethylase 5B		decreases expression	ISO	1	202,696,532	202,777,549	RGD:6480464	CTD
G	KDR	kinase insert domain receptor (a type III receptor tyrosine kinase)		increases expression	EXP	4	55,944,426	55,991,762	RGD:6480464	CTD
G	KHK	ketohexokinase (fructokinase)		decreases expression	ISO	2	27,309,611	27,323,619	RGD:6480464	CTD
G	KIAA0020	KIAA0020		decreases expression	EXP	9	2,804,152	2,844,130	RGD:6480464	CTD
G	KIAA1522	KIAA1522		decreases expression	ISO	1	33,207,512	33,240,571	RGD:6480464	CTD
G	KIF22	kinesin family member 22		decreases expression	EXP	16	29,802,034	29,816,706	RGD:6480464	CTD
G	KIF2C	kinesin family member 2C		decreases expression	EXP	1	45,205,490	45,233,439	RGD:6480464	CTD
G	KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog		decreases activity	EXP	4	55,524,095	55,606,881	RGD:6480464	CTD
G	KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog		increases expression	ISO	4	55,524,095	55,606,881	RGD:6480464	CTD
G	KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog		increases expression	ISO	4	55,524,095	55,606,881	RGD:6480464	CTD
G	KITLG	KIT ligand		increases expression	ISO	12	88,886,570	88,974,250	RGD:6480464	CTD
G	KITLG	KIT ligand		multiple interactions	ISO	12	88,886,570	88,974,250	RGD:6480464	CTD
G	KLF13	Kruppel-like factor 13		decreases expression	ISO	15	31,619,083	31,670,102	RGD:6480464	CTD
G	KLF4	Kruppel-like factor 4 (gut)		increases expression	EXP	9	110,247,133	110,252,047	RGD:6480464	CTD
G	KLF9	Kruppel-like factor 9		decreases expression	ISO	9	72,999,513	73,029,573	RGD:6480464	CTD
G	KLK1	kallikrein 1		decreases expression	ISO	19	51,322,404	51,327,043	RGD:6480464	CTD
G	KLK10	kallikrein-related peptidase 10		increases expression	EXP	19	51,516,000	51,523,431	RGD:6480464	CTD
G	KLK13	kallikrein-related peptidase 13		increases expression	EXP	19	51,559,463	51,568,367	RGD:6480464	CTD
G	KLK7	kallikrein-related peptidase 7		increases expression	EXP	19	51,479,735	51,487,320	RGD:6480464	CTD
G	KLRG1	killer cell lectin-like receptor subfamily G, member 1		decreases expression	ISO	12	9,142,221	9,163,343	RGD:6480464	CTD
G	KPNA1	karyopherin alpha 1 (importin alpha 5)		increases expression	EXP	3	122,140,748	122,233,786	RGD:6480464	CTD
G	KPNA2	karyopherin alpha 2 (RAG cohort 1, importin alpha 1)		decreases expression	EXP	17	66,031,848	66,042,970	RGD:6480464	CTD
G	KPNB1	karyopherin (importin) beta 1		decreases expression	EXP	17	45,727,275	45,761,004	RGD:6480464	CTD
G	KRT1	keratin 1		increases expression	EXP	12	53,068,520	53,074,191	RGD:6480464	CTD
G	KRT1	keratin 1		increases expression	ISO	12	53,068,520	53,074,191	RGD:6480464	CTD
G	KRT1	keratin 1		decreases expression	EXP	12	53,068,520	53,074,191	RGD:6480464	CTD
G	KRT10	keratin 10		decreases expression	EXP	17	38,974,369	38,978,863	RGD:6480464	CTD
G	KRT10	keratin 10		increases expression	EXP	17	38,974,369	38,978,863	RGD:6480464	CTD
G	KRT10	keratin 10		increases expression	EXP	17	38,974,369	38,978,863	RGD:6480464	CTD
G	KRT14	keratin 14		decreases expression	EXP	17	39,738,531	39,743,147	RGD:6480464	CTD
G	KRT14	keratin 14		increases expression	EXP	17	39,738,531	39,743,147	RGD:6480464	CTD
G	KRT15	keratin 15		increases expression	EXP	17	39,669,997	39,675,270	RGD:6480464	CTD
G	KRT17	keratin 17		increases expression	EXP	17	39,775,692	39,780,882	RGD:6480464	CTD
G	KRT17	keratin 17		decreases expression	EXP	17	39,775,692	39,780,882	RGD:6480464	CTD
G	KRT17	keratin 17		decreases expression	ISO	17	39,775,692	39,780,882	RGD:6480464	CTD
G	KRT18	keratin 18		increases expression	EXP	12	53,342,655	53,346,685	RGD:6480464	CTD
G	KRT18	keratin 18		increases expression	EXP	12	53,342,655	53,346,685	RGD:6480464	CTD
G	KRT18	keratin 18		increases expression	ISO	12	53,342,655	53,346,685	RGD:6480464	CTD
G	KRT19	keratin 19		increases expression	EXP	17	39,679,869	39,684,641	RGD:6480464	CTD
G	KRT19	keratin 19		increases expression	EXP	17	39,679,869	39,684,641	RGD:6480464	CTD
G	KRT19	keratin 19		increases expression	EXP	17	39,679,869	39,684,641	RGD:6480464	CTD
G	KRT2	keratin 2		increases expression	EXP	12	53,038,342	53,045,959	RGD:6480464	CTD
G	KRT23	keratin 23 (histone deacetylase inducible)		increases expression	EXP	17	39,078,952	39,093,836	RGD:6480464	CTD
G	KRT4	keratin 4		increases expression	EXP	12	53,200,327	53,207,900	RGD:6480464	CTD
G	KRT5	keratin 5		decreases expression	EXP	12	52,908,359	52,914,243	RGD:6480464	CTD
G	KRT6A	keratin 6A		decreases expression	EXP	12	52,880,958	52,887,181	RGD:6480464	CTD
G	KRT7	keratin 7		increases expression	EXP	12	52,626,954	52,642,709	RGD:6480464	CTD
G	KRT7	keratin 7		increases expression	EXP	12	52,626,954	52,642,709	RGD:6480464	CTD
G	KRT75	keratin 75		decreases expression	EXP	12	52,817,854	52,828,110	RGD:6480464	CTD
G	KRT8	keratin 8		increases expression	EXP	12	53,290,971	53,343,650	RGD:6480464	CTD
G	KRT8	keratin 8		increases expression	EXP	12	53,290,971	53,343,650	RGD:6480464	CTD
G	KRT8	keratin 8		increases expression	ISO	12	53,290,971	53,343,650	RGD:6480464	CTD
G	LY6G6E	lymphocyte antigen 6 complex, locus G6E (pseudogene)		decreases expression	ISO	6	31,679,753	31,681,842	RGD:6480464	CTD
G	LYN	v-yes-1 Yamaguchi sarcoma viral related oncogene homolog		increases expression	EXP	8	56,792,386	56,925,006	RGD:6480464	CTD
G	MAD1L1	MAD1 mitotic arrest deficient-like 1 (yeast)		decreases expression	EXP	7	1,855,428	2,272,583	RGD:6480464	CTD
G	MAF	v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)		increases expression	EXP	16	79,627,745	79,634,622	RGD:6480464	CTD
G	MAGOH	mago-nashi homolog, proliferation-associated (Drosophila)		decreases expression	EXP	1	53,692,564	53,704,282	RGD:6480464	CTD
G	MANEA	mannosidase, endo-alpha		affects expression	ISO	6	96,025,373	96,057,328	RGD:6480464	CTD
G	MAP2	microtubule-associated protein 2		multiple interactions	EXP	2	210,288,771	210,598,834	RGD:6480464	CTD
G	MAP2	microtubule-associated protein 2		increases expression	EXP	2	210,288,771	210,598,834	RGD:6480464	CTD
G	MAP2K1	mitogen-activated protein kinase kinase 1		multiple interactions	EXP	15	66,679,211	66,783,882	RGD:6480464	CTD
G	MAP2K1	mitogen-activated protein kinase kinase 1		decreases expression	EXP	15	66,679,211	66,783,882	RGD:6480464	CTD
G	MAP3K4	mitogen-activated protein kinase kinase kinase 4		decreases expression	ISO	6	161,412,822	161,538,417	RGD:6480464	CTD
G	MAP3K5	mitogen-activated protein kinase kinase kinase 5		decreases expression	ISO	6	136,878,187	137,113,656	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	EXP	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	EXP	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	EXP	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	EXP	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	EXP	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	EXP	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		increases phosphorylation	EXP	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		decreases phosphorylation	EXP	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		increases phosphorylation	ISO	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	ISO	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	ISO	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	ISO	22	22,113,946	22,221,970	RGD:6480464	CTD
G	TAL1	T-cell acute lymphocytic leukemia 1		decreases response to substance	ISO	1	47,681,963	47,695,443	RGD:6480464	CTD
G	TAL1	T-cell acute lymphocytic leukemia 1		decreases expression	ISO	1	47,681,963	47,695,443	RGD:6480464	CTD
G	TMEM254-AS1	TMEM254 antisense RNA 1		increases expression	ISO	10	81,805,989	81,838,949	RGD:6480464	CTD

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	513708
role	503229
chemical role	217197
antioxidant	27619
all-trans-retinoic acid	7404
1-O-all-trans-retinoyl-beta-glucuronic acid	0
4-hydroxyphenyl retinamide	372
all-trans-4-hydroxyretinoic acid	1
vitamin A	0
Path 2
Term	Annotations
CHEBI ontology	513708
subatomic particle	512601
composite particle	512601
hadron	512601
baryon	512601
nucleon	512601
atomic nucleus	512601
atom	512601
main group element atom	480609
p-block element atom	478027
carbon group element atom	427614
carbon atom	424022
organic molecular entity	424015
organic group	174681
organic divalent group	173480
organodiyl group	173480
carbonyl group	173163
carbonyl compound	173163
carboxylic acid	126604
monocarboxylic acid	73216
retinoic acid	8715
all-trans-retinoic acid	7404